The Act creates a tightly regulated statutory scheme authorising voluntary assisted dying in NSW: eligible terminal patients can request VAD through a multi‑step process of practitioner assessments, written requests and review before a prescribed substance may be supplied and used. Oversight and operational discretion sit with a Voluntary Assisted Dying Board and the Health Secretary, who set standards, approve substances and suppliers. The law balances access with safeguards—reporting, penalties, conscientious‑objector protections and judicial review—to manage clinical, administrative and compliance risks.
This Act establishes a statutory process that permits an eligible adult ordinarily resident in New South Wales to request and, subject to prescribed checks and approvals, obtain a voluntary assisted dying substance to cause their death. Mechanically the Act does the following.
Sets a delayed commencement date (s 2) of 18 months after assent. The Crown is bound (s 3).
Creates an eligibility framework for individuals (Pt 2, especially s 15-16): age and residency thresholds, diagnosis and prognosis requirements, suffering not tolerable to the patient, decision-making capacity, voluntariness, absence of pressure or duress and an enduring request.
Prescribes a multi-step clinical pathway (Pts 3-4): a first request (s 19), a first assessment by a coordinating practitioner (ss 24-30), a consulting assessment by an independent consulting practitioner (ss 31-41), a written declaration (ss 43-47), a final request and final review (ss 48-52), a decision whether the patient will self-administer or have practitioner administration (ss 57-60) and steps for prescription, supply, storage and disposal of the substance (ss 59-83).
Establishes the Voluntary Assisted Dying Board (Part 10) with functions that include keeping a list of willing practitioners (s 136(1)(b)), deciding on applications for voluntary assisted dying substance authorities (ss 70-72; 136(1)(d)), collecting and reporting statistical information (ss 136(1)(g), 170) and referring matters to other agencies (s 136(1)(f)).
Provides the Health Secretary with regulatory and guidance powers: approving the class of voluntary assisted dying substances (s 7), issuing an access standard (s 174), approving training and resources (s 180) and issuing guidelines about referral and assessing pressure or duress (s 181).
Current sections
Direct links to the current provisions in Voluntary Assisted Dying Act 2022.
This Act commences on the day that is 18 months after the date of assent to this Act.
3
Act to bind Crown
3 Act to bind Crown
3 Act to bind Crown
This Act binds the Crown in right of New South Wales and, in so far as the legislative power of the Parliament of New South Wales permits, the Crown in all its other capacities.
Division 2
Principles
Division 2 Principles
Division 2 Principles
4
Principles
4 Principles
4 Principles
(1) A person exercising a power or performing a function under this Act must have regard to the following principles—
(a) every human life has equal value,
(b) a person’s autonomy, including autonomy in relation to end of life choices, should be respected,
(c) a person has the right to be supported in making informed decisions about the person’s medical treatment and should be given, in a way the person understands, information about medical treatment options, including comfort and palliative care and treatment,
(d) a person approaching the end of life should be provided with high quality care and treatment, including palliative care and treatment, to minimise the person’s suffering and maximise the person’s quality of life,
(e) a therapeutic relationship between a person and the person’s health practitioner should, wherever possible, be supported and maintained,
(f) a person should be encouraged to openly discuss death and dying, and the person’s preferences and values regarding the person’s care, treatment and end of life should be encouraged and promoted,
(g) a person should be supported in conversations with the person’s health practitioners, family, carers and community about care and treatment preferences,
(h) a person is entitled to genuine choices about the person’s care, treatment and end of life, irrespective of where the person lives in New South Wales and having regard to the person’s culture and language,
(i) a person who is a regional resident is entitled to the same level of access to voluntary assisted dying and high quality care and treatment, including palliative care and treatment, as a person who lives in a metropolitan region,
(j) there is a need to protect persons who may be subject to pressure or duress,
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(k) all persons, including health practitioners, have the right to be shown respect for their culture, religion, beliefs, values and personal characteristics.
(2) In subsection (1), the reference to a person exercising a function under this Act includes the Supreme Court exercising its jurisdiction in relation to a decision made under this Act.
Division 3
Interpretation
Division 3 Interpretation
Division 3 Interpretation
5
Definitions
5 Definitions
5 Definitions
The Dictionary in Schedule 1 defines words and expressions used in this Act.
Note—
The Interpretation Act 1987 also contains definitions and other provisions that affect the interpretation and application of this Act.
6
Decision-making capacity
6 Decision-making capacity
6 Decision-making capacity
(1) For the purposes of this Act, a patient has decision-making capacity in relation to voluntary assisted dying if the patient has the capacity to—
(a) understand information or advice about a voluntary assisted dying decision required under this Act to be provided to the patient, and
(b) remember the information or advice referred to in paragraph (a) to the extent necessary to make a voluntary assisted dying decision, and
(c) understand the matters involved in a voluntary assisted dying decision, and
(d) understand the effect of a voluntary assisted dying decision, and
(e) weigh up the factors referred to in paragraphs (a), (c) and (d) for the purposes of making a voluntary assisted dying decision, and
(f) communicate a voluntary assisted dying decision in some way.
(2) For the purposes of this Act, a patient is—
(a) presumed to have the capacity to understand information or advice about voluntary assisted dying if it reasonably appears the patient is able to understand an explanation of the consequences of making the decision, and
(b) presumed to have decision-making capacity in relation to voluntary assisted dying unless the patient is shown not to have the capacity.
(3) In this section—
voluntary assisted dying decision means—
(a) a request for access to voluntary assisted dying, or
(b) a decision to access voluntary assisted dying.
7
Voluntary assisted dying substance
7 Voluntary assisted dying substance
7 Voluntary assisted dying substance
(1) The Health Secretary may, in writing, approve a Schedule 4 poison or Schedule 8 poison for use under this Act for the purpose of causing a patient’s death.
(2) A poison approved under subsection (1) is a voluntary assisted dying substance.
(3) The Health Secretary must keep a list of voluntary assisted dying substances.
8
When request and assessment process completed
8 When request and assessment process completed
8 When request and assessment process completed
For the purposes of this Act, the request and assessment process has been completed in relation to a patient if the patient’s coordinating practitioner—
(a) has completed the final review form in relation to the patient, and
(b) has certified in the final review form that the request and assessment process has been completed in accordance with this Act.
Division 4
Other provisions
Division 4 Other provisions
Division 4 Other provisions
9
Registered health practitioner may refuse to participate in voluntary assisted dying
9 Registered health practitioner may refuse to participate in voluntary assisted dying
9 Registered health practitioner may refuse to participate in voluntary assisted dying
(1) A registered health practitioner who has a conscientious objection to voluntary assisted dying has the right to refuse to do any of the following—
(a) participate in the request and assessment process,
(b) prescribe, supply or administer a voluntary assisted dying substance,
(c) be present at the time of the administration of a voluntary assisted dying substance.
(2) Subsection (1) does not limit the circumstances in which a registered health practitioner may refuse to do any of the things referred to in the subsection.
10
Health care worker not to initiate discussion about voluntary assisted dying
10 Health care worker not to initiate discussion about voluntary assisted dying
10 Health care worker not to initiate discussion about voluntary assisted dying
(1) A health care worker who provides health services or professional care services to a person must not, while providing the services to the person—
(a) initiate a discussion with the person that is in substance about voluntary assisted dying, or
(b) in substance, suggest voluntary assisted dying to the person.
Note—
A contravention of this Act is capable of constituting unsatisfactory professional conduct or professional misconduct for the purposes of the Health Practitioner Regulation National Law, whether or not the contravention constitutes an offence.
(2) Subsection (1) does not apply to a medical practitioner who initiates a discussion or makes a suggestion referred to in subsection (1)(a) or (b) if, at the time the discussion is initiated or the suggestion is made, the medical practitioner also informs the person about the following—
(a) the treatment options available to the person that would be considered standard care for the disease, illness or medical condition with which the person has been diagnosed,
(b) the likely outcomes of the treatment options available to the person,
(c) the palliative care and treatment options available to the person,
(d) the likely outcomes of the palliative care and treatment options.
(3) Also, subsection (1) does not apply to a health care worker, other than a medical practitioner, who initiates a discussion or makes a suggestion referred to in subsection (1)(a) or (b) if, at the time the discussion is initiated or the suggestion is made, the health care worker also informs the person that the person—
(a) has palliative care and treatment options available, and
(b) should discuss the palliative care and treatment options with the person’s medical practitioner.
(4) To avoid doubt, subsection (1) does not apply to a health care worker who provides information about voluntary assisted dying to a person at the person’s request.
(5) In this section—
health care worker means—
(a) a registered health practitioner, or
(b) another person who provides health services or professional care services.
11
Contravention of Act by registered health practitioner
11 Contravention of Act by registered health practitioner
11 Contravention of Act by registered health practitioner
(1) A contravention of a provision of this Act by a registered health practitioner is capable of constituting unsatisfactory professional conduct or professional misconduct for the purposes of the Health Practitioner Regulation National Law.
(2) Subsection (1) applies whether or not the contravention constitutes an offence under this Act.
12
Voluntary assisted dying not suicide
12 Voluntary assisted dying not suicide
12 Voluntary assisted dying not suicide
(1) For the purposes of the law of the State, a person who dies as the result of the administration of a prescribed substance in accordance with this Act does not die by suicide.
(2) Voluntary assisted dying action does not—
(a) constitute an attempt by the person to cause serious physical harm to the person for the purposes of the Mental Health Act 2007, section 22, or
(b) otherwise provide a ground for a police officer to take action under that section.
(3) In this section—
voluntary assisted dying action means any of the following done in accordance with this Act—
(a) a request for access to voluntary assisted dying,
(b) a self-administration decision or a practitioner administration decision,
(c) self-administration by a person of a prescribed substance,
(d) asking an administering practitioner to administer a prescribed substance.
13
Inherent jurisdiction of Supreme Court not affected
13 Inherent jurisdiction of Supreme Court not affected
13 Inherent jurisdiction of Supreme Court not affected
Nothing in this Act affects the inherent jurisdiction of the Supreme Court.
14
Relationship with Poisons and Therapeutic Goods Act 1966 and Drug Misuse and Trafficking Act 1985
14 Relationship with Poisons and Therapeutic Goods Act 1966 and Drug Misuse and Trafficking Act 1985
(3) To avoid doubt, if a person permanently loses decision-making capacity in relation to voluntary assisted dying at any time during the request and assessment process the person ceases to be eligible for access to voluntary assisted dying under subsection (1)(e).
(4) For subsection (3)—
permanently, for a loss of decision-making capacity in relation to voluntary assisted dying by a person, means the person has lost the capacity to make decisions in relation to voluntary assisted dying forever.
17
Residency exemptions
17 Residency exemptions
17 Residency exemptions
(1) A person may apply to the Board for an exemption from the requirement in section 16(1)(c).
(2) The Board must grant the exemption if satisfied—
(a) the person has a substantial connection to New South Wales, and
Examples—
(b) there are compassionate grounds for granting the exemption.
Part 3
Requesting access to voluntary assisted dying and assessment of eligibility
Part 3 Requesting access to voluntary assisted dying and assessment of eligibility
Part 3 Requesting access to voluntary assisted dying and assessment of eligibility
18
Eligibility to act as coordinating practitioner or consulting practitioner
18 Eligibility to act as coordinating practitioner or consulting practitioner
18 Eligibility to act as coordinating practitioner or consulting practitioner
A medical practitioner is eligible to act as a coordinating practitioner or consulting practitioner for a patient if—
(a) the medical practitioner—
(i) holds specialist registration, or
(ii) holds general registration and has practised the medical profession for at least 10 years as the holder of general registration, and
(b) the medical practitioner has completed the approved training, and
(c) the medical practitioner meets other requirements prescribed by the regulations for the purposes of this section, and
(d) the medical practitioner is not a family member of the patient, and
(e) the medical practitioner does not know or believe that the practitioner—
(i) is a beneficiary under a will of the patient, or
(ii) may otherwise benefit financially or in any other material way from the death of the patient, other than by receiving reasonable fees for the provision of services as the coordinating practitioner or consulting practitioner for the patient.
19
Person may make first request to medical practitioner
19 Person may make first request to medical practitioner
19 Person may make first request to medical practitioner
(1) A person may make a request to a medical practitioner for access to voluntary assisted dying.
(2) The request must be—
(a) clear and unambiguous, and
(b) made during a medical consultation, and
(c) made in person or, if that is not practicable, in accordance with section 176(1)(a).
(3) The person may make the request—
(a) verbally, or
(b) in another way.
Example for paragraph (b)—
by use of gestures
(4) The person may make the request with the assistance of an interpreter.
20
No obligation to continue after making first request
20 No obligation to continue after making first request
20 No obligation to continue after making first request
(1) A person who makes a first request may decide at any time not to continue the request and assessment process.
(2) The request and assessment process ends if the person decides not to continue the process.
(3) If the request and assessment process ends under subsection (2), the person may begin a new request and assessment process by making a new first request.
21
Medical practitioner to accept or refuse first request
21 Medical practitioner to accept or refuse first request
21 Medical practitioner to accept or refuse first request
(1) If a first request is made to a medical practitioner, the practitioner must decide to—
(a) accept the request, or
(b) refuse the request.
(2) The only reasons for which the medical practitioner may decide to refuse the first request are that—
(a) the practitioner has a conscientious objection to voluntary assisted dying or is otherwise unwilling to perform the duties of a coordinating practitioner, or
(b) the practitioner is unable to perform the duties of a coordinating practitioner because of unavailability or another reason, or
(c) the practitioner is required to refuse the request under subsection (3).
(3) The medical practitioner must immediately decide to refuse the first request if the practitioner is not eligible to act as a coordinating practitioner at the time the first request is made.
(4) Unless subsection (5) applies, the medical practitioner must, within 2 business days after the first request is made—
(a) inform the patient that the practitioner has decided to accept or refuse the request, and
(b) give the patient the information approved by the Health Secretary, by Gazette notice, for the purposes of this section.
(5) If the medical practitioner decides to refuse the first request because the practitioner has a conscientious objection to voluntary assisted dying, the practitioner must, immediately after the first request is made, inform the patient the practitioner has decided to refuse the request.
22
Medical practitioner to record first request and acceptance or refusal
22 Medical practitioner to record first request and acceptance or refusal
22 Medical practitioner to record first request and acceptance or refusal
The medical practitioner must record the following in the patient’s medical record—
(a) the first request,
(b) the practitioner’s decision to accept or refuse the first request,
Note—
See section 21(2), which provides the only reasons for which a medical practitioner may refuse a first request.
(c) if the practitioner’s decision is to refuse the first request—the reason for the refusal,
(d) whether the practitioner has given the patient the information referred to in section 21(4)(b) and (5).
23
Medical practitioner to notify Board of first request
23 Medical practitioner to notify Board of first request
23 Medical practitioner to notify Board of first request
(1) Within 5 business days after deciding to accept or refuse the first request, the medical practitioner must—
(a) complete the approved form (the first request form), and
(b) give a copy of the first request form to the Board.
(2) The first request form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the medical practitioner’s name and contact details,
(c) the date the first request was made,
(d) whether the first request was made in person or using audiovisual communication,
(e) whether the first request was made verbally or in another way,
(f) if the patient was assisted by an interpreter to make the first request—the interpreter’s name, contact details and accreditation details,
(g) the medical practitioner’s decision to accept or refuse the first request,
(h) if the medical practitioner’s decision is to refuse the first request—the reason for the refusal,
(i) the date the medical practitioner informed the patient of the practitioner’s decision and gave the patient the information referred to in section 21(4)(b) or (5),
(j) the medical practitioner’s signature and the date the form was signed.
24
Medical practitioner becomes coordinating practitioner if first request accepted
24 Medical practitioner becomes coordinating practitioner if first request accepted
24 Medical practitioner becomes coordinating practitioner if first request accepted
If the medical practitioner accepts the first request, the practitioner becomes the coordinating practitioner for the patient.
25
First assessment
25 First assessment
25 First assessment
(1) The coordinating practitioner for a patient must assess whether the patient is eligible for access to voluntary assisted dying.
(2) For the purposes of subsection (1), the coordinating practitioner must make a decision in relation to each of the eligibility criteria.
(3) Nothing in this section prevents the coordinating practitioner from having regard to relevant information about the patient that has been prepared by, or at the instigation of, another registered health practitioner.
26
Referral to another medical practitioner for opinion—disease, illness or medical condition
26 Referral to another medical practitioner for opinion—disease, illness or medical condition
26 Referral to another medical practitioner for opinion—disease, illness or medical condition
(1) This section applies if the coordinating practitioner is unable to decide whether the patient has a disease, illness or medical condition that meets the requirements of section 16(1)(d).
(2) The coordinating practitioner must refer the patient to a medical practitioner who has appropriate skills and training to make a decision about the matter.
Note—
See section 181(2)(a) about guidelines that apply to the referral.
(3) The medical practitioner must—
(a) decide whether the patient has a disease, illness or medical condition that—
(i) is advanced, progressive and will cause death, and
(ii) will, on the balance of probabilities, cause death—
(A) for a disease, illness or medical condition that is neurodegenerative—within a period of 12 months, or
(B) otherwise—within a period of 6 months, and
(iii) is causing suffering to the person that cannot be relieved in a way the person considers tolerable, and
(b) provide a clinical report to the coordinating practitioner that sets out the medical practitioner’s decision.
(4) If the coordinating practitioner makes a referral under this section, the coordinating practitioner may adopt the decision of the medical practitioner about the matter in relation to which the referral was made.
(5) A medical practitioner to whom the patient is referred under this section must not be—
(a) a family member of the patient, or
(b) a person who knows or believes that they—
(i) are a beneficiary under a will of the patient, or
(ii) may otherwise benefit financially or in any other material way from the death of the patient, other than by receiving reasonable fees for the provision of services in connection with the referral.
27
Referral for opinion—other matters
27 Referral for opinion—other matters
27 Referral for opinion—other matters
(1) This section applies if the coordinating practitioner is unable to decide whether—
(a) as required by section 16(1)(e), the patient has decision-making capacity in relation to voluntary assisted dying, or
Example—
due to a past or current mental illness of the patient
(b) as required by section 16(1)(f), the patient is acting voluntarily, or
(c) as required by section 16(1)(g), the patient is not acting because of pressure or duress.
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(2) The coordinating practitioner must refer the patient to—
(a) if the coordinating practitioner is unable to decide whether the patient has decision-making capacity in relation to voluntary assisted dying—a psychiatrist or another registered health practitioner who has appropriate skills and training to make a decision about the matter, or
(b) if the coordinating practitioner is unable to decide whether the patient is or is not acting voluntarily or whether the patient is or is not acting because of pressure or duress—a psychiatrist or another registered health practitioner or person who has appropriate skills and training to make a decision about the matter.
Note—
See section 181(2)(b) about guidelines that apply to the referral.
(3) If the coordinating practitioner makes a referral under this section, the coordinating practitioner may adopt the decision of the psychiatrist, other registered health practitioner or other person about the matter in relation to which the referral was made.
(4) A psychiatrist, registered health practitioner or other person to whom the patient is referred under this section must not be—
(a) a family member of the patient, or
(b) a person who knows or believes that they—
(i) are a beneficiary under a will of the patient, or
(ii) may otherwise benefit financially or in any other material way from the death of the patient, other than by receiving reasonable fees for the provision of services in connection with the referral.
28
Information to be provided if patient assessed as meeting eligibility criteria
28 Information to be provided if patient assessed as meeting eligibility criteria
28 Information to be provided if patient assessed as meeting eligibility criteria
(1) If the coordinating practitioner is satisfied the patient meets all of the eligibility criteria, the coordinating practitioner must inform the patient about the following matters—
(a) the patient’s diagnosis and prognosis,
(b) the treatment options available to the patient that would be considered standard care for the disease, illness or medical condition with which the patient has been diagnosed and the likely outcomes of treatment,
(c) the palliative care and treatment options available to the patient and the likely outcomes of the care and treatment,
(d) the potential risks of self-administering or being administered a voluntary assisted dying substance likely to be prescribed under this Act for the purposes of causing the patient’s death,
(e) that the expected outcome of self-administering or being administered a substance referred to in paragraph (d) is death,
(f) the method by which a substance referred to in paragraph (d) is likely to be self-administered or administered,
(g) the request and assessment process, including the requirement for a written declaration signed by the patient, or a person on the patient’s behalf, in the presence of 2 witnesses,
(h) that if the patient makes a self-administration decision, the patient must appoint a contact person,
(i) that the patient may decide at any time not to continue the request and assessment process or not to access voluntary assisted dying,
(j) it is unlawful for a person to apply pressure or duress on the patient to request voluntary assisted dying or to continue the request and assessment process,
Note—
See the Crimes Act 1900, section 41C for the relevant offence
(k) that if the patient is receiving ongoing health services from a medical practitioner (the treating practitioner) other than the coordinating practitioner—
(i) the patient is encouraged to inform the treating practitioner about the patient’s request for access to voluntary assisted dying, and
(ii) it is unlawful for the treating practitioner to withdraw other services the practitioner would usually provide to the patient or the patient’s family and other close contacts because of the patient’s request for access to voluntary assisted dying, and
(iii) if the treating practitioner withdraws services mentioned in subparagraph (ii)—the matter should be the subject of a complaint to the Health Care Complaints Commission under the Health Care Complaints Act 1993,
(l) that if the patient is a resident of a residential facility, whether permanently or not, the patient should inform the residential facility manager about the patient’s request for access to voluntary assisted dying.
(2) For the purposes of subsection (1)(d), if the access standard includes information about the potential risks of self-administering or being administered a voluntary assisted dying substance likely to be prescribed under this Act for the purposes of causing the patient’s death, the information must be given in accordance with the access standard.
Note—
See section 174(3), which provides that the access standard may include information about the potential risks of self-administering or being administered a voluntary assisted dying substance likely to be prescribed under this Act for the purposes of causing a patient’s death.
(3) The withdrawal of services by a medical practitioner in circumstances mentioned in subsection (1)(k)(ii) may be unsatisfactory professional conduct for the purposes of the Health Practitioner Regulation National Law.
(4) In addition to informing the patient about the matters referred to in subsection (1), the coordinating practitioner must take all reasonable steps to fully explain to the patient and, if the patient consents, another person nominated by the patient—
(a) all relevant clinical guidelines, and
(b) a plan in relation to the administration of a voluntary assisted dying substance.
(5) Nothing in this section affects a duty a medical practitioner has—
(a) at common law, or
(b) under another Act or other law.
29
Outcome of first assessment
29 Outcome of first assessment
29 Outcome of first assessment
(1) The coordinating practitioner must assess the patient as eligible for access to voluntary assisted dying if the coordinating practitioner is satisfied—
(a) the patient meets all of the eligibility criteria, and
(b) the patient understands the information required to be provided under section 28(1).
(2) If the coordinating practitioner is not satisfied about a matter in subsection (1)—
(a) the coordinating practitioner must assess the patient as ineligible for access to voluntary assisted dying, and
(b) the request and assessment process ends.
Note—
See sections 26 and 27, which provide that the coordinating practitioner may, in certain circumstances, refer a patient to another registered health practitioner or another person if the coordinating practitioner is unable to make a decision about eligibility for access to voluntary assisted dying.
30
Recording and notification of outcome of first assessment
30 Recording and notification of outcome of first assessment
30 Recording and notification of outcome of first assessment
(1) The coordinating practitioner must inform the patient of the outcome of the first assessment as soon as practicable after its completion.
(2) Within 5 business days after completing the first assessment, the coordinating practitioner must—
(a) complete the approved form (the first assessment report form), and
(b) give a copy of the first assessment report form to the Board.
Maximum penalty—100 penalty units.
(3) As soon as practicable after completing the first assessment report form, the coordinating practitioner must give a copy of the form to the patient.
(4) The first assessment report form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the following information about the patient—
(i) gender,
(ii) nationality,
(iii) ethnicity,
(iv) whether the patient has a disability and, if so, details of the disability,
(v) whether the patient’s first language is a language other than English,
(vi) whether the coordinating practitioner engaged an interpreter in accordance with section 176(2) to communicate the information in section 28(1) and (4) to the patient,
(c) the coordinating practitioner’s name and contact details,
(d) a statement confirming the coordinating practitioner meets the requirements of section 18,
(e) the date the first request was made,
(f) the date the first assessment was completed,
(g) the outcome of the first assessment, including the coordinating practitioner’s decision about each of the eligibility criteria,
(h) the date the patient was informed of the outcome of the first assessment,
(i) if the patient was referred under section 26(2) or 27(2)—the outcome of the referral, including a copy of a report given by the registered health practitioner or other person to whom the patient was referred,
(j) if the patient was assisted by an interpreter when having the first assessment—the interpreter’s name, contact details and accreditation details,
(k) the palliative care and treatment options available to the patient and the likely outcomes of the care and treatment,
(l) a statement confirming the patient has been advised of the palliative care and treatment options available to the patient and the likely outcomes of the care and treatment,
(m) a statement confirming the patient has been advised it is unlawful for a person to apply pressure or duress on the patient to request voluntary assisted dying or to continue the request and assessment process,
Note—
See the Crimes Act 1900, section 41C for the relevant offence
(n) a statement confirming the coordinating practitioner has asked the patient whether the patient has experienced pressure or duress to request access to voluntary assisted dying from a person who is a beneficiary under the patient’s will or may otherwise benefit financially or in another material way from the patient’s death,
(o) a statement confirming the coordinating practitioner has acted in accordance with guidelines under section 181 in relation to the following matters—
(i) deciding whether to refer the patient to a specialist under section 26,
(ii) deciding whether to refer the patient to a psychiatrist, another registered health practitioner or another person under section 27,
(p) a statement confirming the coordinating practitioner has acted in accordance with guidelines under section 181 in determining whether the patient has experienced pressure or duress to request access to voluntary assisted dying,
(q) the coordinating practitioner’s signature and the date the form was signed.
31
Referral for consulting assessment if patient assessed as eligible
31 Referral for consulting assessment if patient assessed as eligible
31 Referral for consulting assessment if patient assessed as eligible
If the coordinating practitioner assesses the patient as eligible for access to voluntary assisted dying, the practitioner must refer the patient to another medical practitioner for a consulting assessment.
32
Medical practitioner to accept or refuse referral for consulting assessment
32 Medical practitioner to accept or refuse referral for consulting assessment
32 Medical practitioner to accept or refuse referral for consulting assessment
(1) If a patient is referred to a medical practitioner for a consulting assessment under section 31, 42 or 175(6)(a), the practitioner must decide to accept or refuse the referral.
(2) The reasons for which the medical practitioner may decide to refuse the referral are that—
(a) the practitioner has a conscientious objection to voluntary assisted dying or is otherwise unwilling to perform the duties of a consulting practitioner, or
(b) the practitioner is unable to perform the duties of a consulting practitioner because of unavailability or some other reason, or
(c) the practitioner is required to refuse the referral under subsection (3).
(3) The medical practitioner must decide to refuse the referral if the practitioner is not eligible to act as a consulting practitioner.
(4) Unless subsection (5) applies, the medical practitioner must, within 2 business days after receiving the referral, inform the patient and the patient’s coordinating practitioner that the practitioner has decided to—
(a) accept the referral, or
(b) refuse the referral.
(5) If the medical practitioner decides to refuse the referral because the practitioner has a conscientious objection to voluntary assisted dying, the practitioner must, immediately after receiving the referral, inform the patient and the patient’s coordinating practitioner that the practitioner has decided to refuse the referral.
33
Medical practitioner to record referral and acceptance or refusal
33 Medical practitioner to record referral and acceptance or refusal
33 Medical practitioner to record referral and acceptance or refusal
The medical practitioner must record the following in the patient’s medical record—
(a) the referral,
(b) the practitioner’s decision to accept or refuse the referral,
(c) if the practitioner’s decision is to refuse the referral—the reason for the refusal.
34
Medical practitioner to notify Board of referral
34 Medical practitioner to notify Board of referral
34 Medical practitioner to notify Board of referral
(1) Within 5 business days after deciding to accept or refuse the referral, the medical practitioner must—
(a) complete the approved form (the consultation referral form), and
(b) give a copy of the consultation referral form to the Board.
Maximum penalty—100 penalty units.
(2) The consultation referral form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the medical practitioner’s name and contact details,
(c) the date the referral was received,
(d) the medical practitioner’s decision to accept or refuse the referral,
(e) if the medical practitioner’s decision is to refuse the referral—the reason for the refusal,
(f) the date the medical practitioner informed the patient and the patient’s coordinating practitioner of the medical practitioner’s decision,
(g) the medical practitioner’s signature and the date the form was signed.
35
Medical practitioner becomes consulting practitioner if referral accepted
35 Medical practitioner becomes consulting practitioner if referral accepted
35 Medical practitioner becomes consulting practitioner if referral accepted
If the medical practitioner accepts the referral, the practitioner becomes the consulting practitioner for the patient.
36
Consulting assessment
36 Consulting assessment
36 Consulting assessment
(1) The consulting practitioner for a patient must assess whether the patient is eligible for access to voluntary assisted dying.
(2) For the purposes of subsection (1), the consulting practitioner must—
(a) make a decision about each of the eligibility criteria, and
(b) independently of the coordinating practitioner, form the practitioner’s own opinions on the matters to be decided.
(3) Nothing in this section prevents the consulting practitioner having regard to relevant information about the patient that has been prepared by, or at the instigation of, another registered health practitioner.
37
Referral to another medical practitioner for opinion—disease, illness or medical condition
37 Referral to another medical practitioner for opinion—disease, illness or medical condition
37 Referral to another medical practitioner for opinion—disease, illness or medical condition
(1) This section applies if the consulting practitioner is unable to decide whether the patient has a disease, illness or medical condition that meets the requirements of section 16(1)(d).
(2) The consulting practitioner must refer the patient to a medical practitioner who has appropriate skills and training to make a decision about the matter.
Note—
See section 181(2)(a) about guidelines that apply to the referral.
(3) The medical practitioner must—
(a) decide whether the patient has a disease, illness or medical condition that—
(i) is advanced, progressive and will cause death, and
(ii) will, on the balance of probabilities, cause death—
(A) for a disease, illness or medical condition that is neurodegenerative—within a period of 12 months, or
(B) otherwise—within a period of 6 months, and
(iii) is causing suffering to the person that cannot be relieved in a way the person considers tolerable, and
(b) provide a clinical report to the consulting practitioner that sets out the medical practitioner’s decision.
(4) If the consulting practitioner makes a referral under this section, the consulting practitioner may adopt the decision of the medical practitioner about the matter in relation to which the referral was made.
(5) A medical practitioner to whom the patient is referred under this section must not be—
(a) a family member of the patient, or
(b) a person who knows or believes that they—
(i) are a beneficiary under a will of the patient, or
(ii) may otherwise benefit financially or in any other material way from the death of the patient, other than by receiving reasonable fees for the provision of services in connection with the referral.
38
Referral for opinion—other matters
38 Referral for opinion—other matters
38 Referral for opinion—other matters
(1) This section applies if the consulting practitioner is unable to decide whether—
(a) as required by section 16(1)(e), the patient has decision-making capacity in relation to voluntary assisted dying, or
Example—
due to a past or current mental illness of the patient
(b) as required by section 16(1)(f), the patient is acting voluntarily, or
(c) as required by section 16(1)(g), the patient is not acting because of pressure or duress.
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(2) The consulting practitioner must refer the patient to—
(a) if the consulting practitioner is unable to decide whether the patient has decision-making capacity in relation to voluntary assisted dying—a psychiatrist or another registered health practitioner who has appropriate skills and training to make a decision about the matter, or
(b) if the consulting practitioner is unable to decide whether the patient is or is not acting voluntarily or is or is not acting because of pressure or duress—a psychiatrist or another registered health practitioner or person who has appropriate skills and training to make a decision about the matter.
Note—
See section 181(2)(b) about guidelines that apply to the referral.
(3) If the consulting practitioner makes a referral under this section, the consulting practitioner may adopt the decision of the psychiatrist, other registered health practitioner or other person about the matter in relation to which the referral was made.
(4) A psychiatrist, registered health practitioner or other person to whom the patient is referred under this section must not be—
(a) a family member of the patient, or
(b) a person who knows or believes that they—
(i) are a beneficiary under a will of the patient, or
(ii) may otherwise benefit financially or in any other material way from the death of the patient, other than by receiving reasonable fees for the provision of services in connection with the referral.
39
Information to be provided if patient assessed as meeting eligibility criteria
39 Information to be provided if patient assessed as meeting eligibility criteria
39 Information to be provided if patient assessed as meeting eligibility criteria
(1) If the consulting practitioner is satisfied the patient meets all of the eligibility criteria, the consulting practitioner must give the patient information about the matters referred to in section 28(1).
(2) Nothing in this section affects a duty a medical practitioner—
(a) has at common law, or
(b) under another Act or law.
40
Outcome of consulting assessment
40 Outcome of consulting assessment
40 Outcome of consulting assessment
(1) The consulting practitioner must assess the patient as eligible for access to voluntary assisted dying if the consulting practitioner is satisfied—
(a) the patient meets all of the eligibility criteria, and
(b) the patient understands the information required to be given under section 39(1).
(2) If the consulting practitioner is not satisfied about a matter in subsection (1), the consulting practitioner must assess the patient as ineligible for access to voluntary assisted dying.
41
Recording and notification of outcome of consulting assessment
41 Recording and notification of outcome of consulting assessment
41 Recording and notification of outcome of consulting assessment
(1) The consulting practitioner must inform the patient and the patient’s coordinating practitioner of the outcome of the consulting assessment as soon as practicable after its completion.
(2) Within 5 business days after completing the consulting assessment, the consulting practitioner must—
(a) complete the approved form (the consulting assessment report form) in relation to the patient, and
(b) give a copy of the consulting assessment report form to the Board.
Maximum penalty—100 penalty units.
(3) As soon as practicable after completing the consulting assessment report form, the consulting practitioner must give a copy of the form to the patient.
(4) The consulting assessment report form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the consulting practitioner’s name and contact details,
(c) a statement confirming the consulting practitioner meets the requirements of section 18,
(d) the date the referral for the consulting assessment was made,
(e) the date the referral for the consulting assessment was received,
(f) the date the consulting assessment was completed,
(g) the outcome of the consulting assessment, including the consulting practitioner’s decision about each of the eligibility criteria,
(h) the date the patient was informed of the outcome of the consulting assessment,
(i) the date the patient’s coordinating practitioner was informed of the outcome of the consulting assessment,
(j) if the patient was referred under section 37(2) or 38(2)—the outcome of the referral, including a copy of a report given by the registered health practitioner or other person to whom the patient was referred,
(k) if the patient was assisted by an interpreter when having the consulting assessment—the interpreter’s name, contact details and accreditation details,
(l) the palliative care and treatment options available to the patient and the likely outcomes of the care and treatment,
(m) a statement confirming the patient has been advised it is unlawful for a person to apply pressure or duress on the patient to request voluntary assisted dying or to continue the request and assessment process,
Note—
See the Crimes Act 1900, section 41C for the relevant offence
(n) a statement confirming the practitioner has asked the patient whether the patient has experienced pressure or duress to request access to voluntary assisted dying from a person who is a beneficiary under the patient’s will or may otherwise benefit financially or in another material way from the patient’s death,
(o) a statement confirming the consulting practitioner has acted in accordance with guidelines under section 181 in relation to the following matters—
(i) deciding whether to refer the patient to a medical practitioner under section 26,
(ii) deciding whether to refer the patient to a psychiatrist, another registered health practitioner or another person under section 27,
(p) a statement confirming the consulting practitioner has acted in accordance with guidelines under section 181 in determining whether the patient has experienced pressure or duress to request access to voluntary assisted dying,
(q) the consulting practitioner’s signature and the date the form was signed.
(5) The consulting practitioner must give a copy of the consulting assessment report form to the patient’s coordinating practitioner as soon as practicable after completing the consulting assessment.
42
Referral for further consulting assessment if patient assessed as ineligible
42 Referral for further consulting assessment if patient assessed as ineligible
42 Referral for further consulting assessment if patient assessed as ineligible
If the consulting practitioner assesses the patient as ineligible for access to voluntary assisted dying, the patient’s coordinating practitioner may refer the patient to another medical practitioner for a further consulting assessment.
Division 5
Written declaration
Division 5 Written declaration
Division 5 Written declaration
43
Patient assessed as eligible may make written declaration
43 Patient assessed as eligible may make written declaration
43 Patient assessed as eligible may make written declaration
(1) A patient may make a written declaration requesting access to voluntary assisted dying if the patient has been assessed as eligible for access to voluntary assisted dying by—
(a) the patient’s coordinating practitioner, and
(b) the patient’s consulting practitioner.
(2) The written declaration must be—
(a) in the approved form, and
(b) given to the patient’s coordinating practitioner.
(3) The written declaration must—
(a) state that the patient—
(i) makes the declaration voluntarily, and
(ii) does not make the declaration because of pressure or duress, and
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(iii) understands its nature and effect, and
(b) be signed by the patient, or a person referred to in subsection (4), in the presence of 2 witnesses, and
(c) include the following—
(i) the patient’s name, date of birth and contact details,
(ii) if the patient was assisted by an interpreter—the interpreter’s name, contact details and accreditation details,
(iii) the name and contact details of the patient’s coordinating practitioner.
(4) A person may sign the written declaration on behalf of the patient if—
(a) the patient is unable to sign the declaration, and
(b) the patient directs the person to sign the declaration, and
(c) the person—
(i) is an adult, and
(ii) is not a witness to the signing of the declaration, and
(iii) is not the coordinating practitioner or consulting practitioner for the patient making the declaration.
(5) A person who signs the written declaration on behalf of the patient must do so in the patient’s presence.
(6) If the patient makes the written declaration with the assistance of an interpreter, the interpreter must certify on the declaration that the interpreter provided a true and correct translation of any material translated.
44
Witness to signing of written declaration
44 Witness to signing of written declaration
44 Witness to signing of written declaration
(1) For the purposes of section 43(3)(b), a person is eligible to witness the signing of a written declaration if the person—
(a) is an adult, and
(b) is not an ineligible witness.
(2) For the purposes of subsection (1)(b), a person is an ineligible witness if the person—
(a) knows or believes the person—
(i) is a beneficiary under a will of the patient making the declaration, or
(ii) may otherwise benefit financially or in any other material way from the death of the patient making the declaration, or
(b) is a family member of the patient making the declaration, or
(c) is the coordinating practitioner or consulting practitioner for the patient making the declaration, or
(d) is a family member or employee of the coordinating practitioner or consulting practitioner for the patient making the declaration.
45
Certification of witness to signing of written declaration
45 Certification of witness to signing of written declaration
45 Certification of witness to signing of written declaration
(1) A person who witnesses the signing of a written declaration by the patient making the declaration must—
(a) certify in writing in the declaration that, in the presence of the witness, the patient appeared to freely and voluntarily sign the declaration, and
(b) state that the witness is not knowingly an ineligible witness.
(2) A person who witnesses the signing of a written declaration by another person on behalf of the patient making the declaration must—
(a) certify in writing in the declaration that—
(i) in the presence of the witness, the patient appeared to freely and voluntarily direct the other person to sign the declaration, and
(ii) the other person signed the declaration in the presence of the patient and the witness, and
(b) state that the witness is not knowingly an ineligible witness.
(3) In this section—
ineligible witness means a person who is an ineligible witness under section 44(2).
46
Coordinating practitioner to record written declaration
46 Coordinating practitioner to record written declaration
46 Coordinating practitioner to record written declaration
If a patient gives a written declaration to the patient’s coordinating practitioner, the coordinating practitioner must record the following in the patient’s medical record—
(a) the date the written declaration was made,
(b) the date the written declaration was received by the coordinating practitioner.
47
Coordinating practitioner to notify Board of written declaration
47 Coordinating practitioner to notify Board of written declaration
47 Coordinating practitioner to notify Board of written declaration
Within 5 business days after receiving a written declaration made by a patient, the patient’s coordinating practitioner must give a copy of the declaration to the Board.
Maximum penalty—100 penalty units.
Division 6
Final request and final review
Division 6 Final request and final review
Division 6 Final request and final review
48
Patient may make final request to coordinating practitioner
48 Patient may make final request to coordinating practitioner
48 Patient may make final request to coordinating practitioner
(1) A patient who has made a written declaration may make a final request to the patient’s coordinating practitioner for access to voluntary assisted dying.
(2) The final request must be—
(a) clear and unambiguous, and
(b) made in person or, if that is not practicable, in accordance with section 176(1)(a).
(3) The patient may make the final request—
(a) verbally, or
(b) in another way.
Example for paragraph (b)—
by use of gestures
49
When final request may be made
49 When final request may be made
49 When final request may be made
(1) The final request must not be made—
(a) before the end of the designated period, except as provided in subsection (2), and
(b) until after the day on which the consulting assessment that assessed the patient as eligible for access to voluntary assisted dying was completed.
(2) The final request may be made before the end of the designated period if—
(a) in the reasonable opinion of the patient’s coordinating practitioner, the patient is likely to die, or to lose decision-making capacity in relation to voluntary assisted dying, before the end of the designated period, and
(b) the coordinating practitioner’s opinion is consistent with the opinion of the patient’s consulting practitioner.
50
Coordinating practitioner to record final request
50 Coordinating practitioner to record final request
50 Coordinating practitioner to record final request
The patient’s coordinating practitioner must record in the patient’s medical record—
(a) the date the final request was made, and
(b) if the final request was made before the end of the designated period—the reason for the final request being made before the end of the period.
51
Coordinating practitioner to notify Board of final request
51 Coordinating practitioner to notify Board of final request
51 Coordinating practitioner to notify Board of final request
(1) Within 5 business days after receiving a final request made by a patient, the patient’s coordinating practitioner must—
(a) complete the approved form (the final request form), and
(b) give a copy of the final request form to the Board.
Maximum penalty—100 penalty units.
(2) The final request form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the coordinating practitioner’s name and contact details,
(c) the date the first request was made,
(d) the date the final request was made,
(e) whether the final request was made in person or using audiovisual communication,
(f) whether the final request was made verbally or in another way,
(g) if the patient was assisted by an interpreter when making the final request—the interpreter’s name, contact details and accreditation details,
(h) if the final request was made before the end of the designated period—the reason for the final request being made before the end of the period,
(i) the coordinating practitioner’s signature and the date the form was signed.
52
Final review by coordinating practitioner on receiving final request
52 Final review by coordinating practitioner on receiving final request
52 Final review by coordinating practitioner on receiving final request
(1) On receiving a final request made by a patient, the coordinating practitioner for the patient must—
(a) review all consulting assessment report forms in relation to the patient, and
(b) review the patient’s written declaration, and
(c) complete the approved form (the final review form) in relation to the patient.
(2) In conducting the final review, the coordinating practitioner must have regard to a decision made by the Supreme Court under Part 6 in relation to a decision made in the request and assessment process.
(3) The final review form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the coordinating practitioner’s name and contact details,
(c) a statement that the coordinating practitioner has reviewed—
(i) all consulting assessment report forms in relation to the patient, and
(ii) the patient’s written declaration,
(d) a statement certifying whether or not the request and assessment process has been completed in accordance with this Act,
(e) if the patient was assisted by an interpreter—the interpreter’s name, contact details and accreditation details,
(f) a statement certifying whether or not the coordinating practitioner is satisfied that—
(i) the patient has decision-making capacity in relation to voluntary assisted dying, and
(ii) the patient, in requesting access to voluntary assisted dying, is acting voluntarily, and
(iii) the patient, in requesting access to voluntary assisted dying, is not acting because of pressure or duress, and
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(iv) the patient’s request to access voluntary assisted dying is enduring,
(g) the coordinating practitioner’s signature and the date the form was signed.
(4) Within 5 business days after completing the final review form, the coordinating practitioner must give a copy of the form to the Board.
Maximum penalty—100 penalty units.
53
Technical error not to invalidate request and assessment process
53 Technical error not to invalidate request and assessment process
53 Technical error not to invalidate request and assessment process
The validity of the request and assessment process is not affected by—
(a) a minor or technical error in a document under this Act, including, for example—
(i) a final review form, or
(ii) a consulting assessment report form, or
(iii) a patient’s written declaration, or
(iv) a prescription, or
(b) the failure of a person to provide a form within the time required under this Act.
54
No obligation for patient to continue after completion of request and assessment process
54 No obligation for patient to continue after completion of request and assessment process
54 No obligation for patient to continue after completion of request and assessment process
A patient for whom the request and assessment process has been completed may decide at any time not to take any further step in relation to access to voluntary assisted dying.
Part 4
Accessing voluntary assisted dying and death
Part 4 Accessing voluntary assisted dying and death
Part 4 Accessing voluntary assisted dying and death
55
Eligibility to act as administering practitioner
55 Eligibility to act as administering practitioner
55 Eligibility to act as administering practitioner
A person is eligible to act as an administering practitioner for a patient if—
(a) the person is—
(i) a medical practitioner who holds specialist registration, or
(ii) a medical practitioner who holds general registration and has practised the medical profession for at least 5 years, or
(iii) a medical practitioner who is an overseas-trained specialist who holds limited registration or provisional registration, or
(iv) a nurse practitioner, and
(b) the person has completed approved training, and
(c) the person meets other requirements prescribed by the regulations for the purposes of this section, and
(d) the person is not a family member of the patient, and
(e) the person does not know or believe that the person—
(i) is a beneficiary under a will of the patient, or
(ii) may otherwise benefit financially or in any other material way from the death of the patient, other than by receiving reasonable fees for the provision of services as the administering practitioner for the patient.
56
Application of Division
56 Application of Division
56 Application of Division
This Division applies if—
(a) the request and assessment process has been completed in relation to a patient, and
(b) the final review form for the patient certifies that the coordinating practitioner for the patient is satisfied—
(i) the patient has decision-making capacity in relation to voluntary assisted dying, and
(ii) the patient, in requesting access to voluntary assisted dying, is acting voluntarily, and
(iii) the patient, in requesting access to voluntary assisted dying, is not acting because of pressure or duress, and
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(iv) the patient’s request to access voluntary assisted dying is enduring.
57
Administration decision
57 Administration decision
57 Administration decision
(1) The patient may, in consultation with and on the advice of the patient’s coordinating practitioner—
(a) decide to self-administer a voluntary assisted dying substance (a self-administration decision), or
(b) decide a voluntary assisted dying substance is to be administered to the patient by the administering practitioner for the patient (a practitioner administration decision).
(2) An administration decision must be—
(a) clear and unambiguous, and
(b) made in person before the patient’s coordinating practitioner or, if that is not practicable, in accordance with section 176(1)(a).
(3) The patient may make an administration decision—
(a) verbally, or
(b) in another way.
Example for paragraph (b)—
by use of gestures
(4) The patient may make the administration decision with the assistance of an interpreter.
(5) If the patient makes an administration decision, the patient’s coordinating practitioner must record the decision in the patient’s medical record.
(6) The patient’s coordinating practitioner must also, within 5 business days after the patient makes an administration decision—
(a) complete the approved form for the administration decision (the administration decision form) as required by subsection (7), and
(b) give the Board a copy of the administration decision form.
Maximum penalty—100 penalty units.
(7) The administration decision form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the coordinating practitioner’s name and contact details,
(c) the administration decision made by the patient,
(d) the date the administration decision was made,
(e) if the patient was assisted by an interpreter when making the administration decision—the interpreter’s name, contact details and accreditation details,
(f) the coordinating practitioner’s name and the date the form was signed.
58
Revocation of administration decision
58 Revocation of administration decision
58 Revocation of administration decision
(1) The patient may at any time—
(a) revoke a self-administration decision by informing the patient’s coordinating practitioner the patient has decided not to self-administer a voluntary assisted dying substance, or
(b) revoke a practitioner administration decision by informing the patient’s administering practitioner the patient has decided not to proceed with the administration of a voluntary assisted dying substance.
(2) A decision to revoke an administration decision must be clear and unambiguous.
(3) For the purposes of subsection (1), the patient may inform the coordinating practitioner or administering practitioner of the patient’s decision—
(a) in writing, or
(b) verbally, or
(c) in another way.
Example for paragraph (c)—
by use of gestures
(4) The patient may inform the coordinating practitioner or administering practitioner of the patient’s decision with the assistance of an interpreter.
(5) If the patient revokes an administration decision under subsection (1), the coordinating practitioner or administering practitioner who is informed of the patient’s decision must—
(a) record the revocation in the patient’s medical record, and
(b) if the practitioner is not the patient’s coordinating practitioner—inform the coordinating practitioner of the revocation, and
(c) within 5 business days after the revocation—
(i) complete the approved form (the revocation form), and
(ii) give a copy of the revocation form to the Board.
Maximum penalty—100 penalty units.
(6) The revocation form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the name and contact details of the person completing the form,
(c) if the person completing the form is not the patient’s coordinating practitioner—the coordinating practitioner’s name and contact details,
(d) the date the administration decision was revoked,
(e) any reason given by the patient for the revocation of the administration decision,
(f) if the patient was assisted by an interpreter when revoking the administration decision—the interpreter’s name, contact details and accreditation details,
(g) the signature of the person completing the form and the date the form was signed.
(7) The revocation of an administration decision does not prevent the patient from making another administration decision under section 57(1).
59
Self-administration
59 Self-administration
59 Self-administration
(1) This section applies if the patient—
(a) has made a self-administration decision, and
(b) has not revoked the decision.
(2) The coordinating practitioner for the patient is authorised to prescribe a voluntary assisted dying substance for the patient that is of a sufficient dose to cause death.
(3) To avoid doubt, subsection (2) is subject to—
(a) the contact person appointment form having been given to the coordinating practitioner as required by section 67(5), and
(b) the Board having granted a voluntary assisted dying substance authority under section 71 in relation to the patient.
(4) The authorised supplier who is given the prescription for the patient is authorised to—
(a) possess the prescribed substance for the purpose of preparing and supplying the substance to a person referred to in paragraph (c), and
(b) prepare the prescribed substance, and
(c) supply the prescribed substance to the patient, the contact person for the patient or an agent of the patient.
(5) The patient is authorised to—
(a) receive the prescribed substance from an authorised supplier, the contact person for the patient or an agent of the patient, and
(b) possess the prescribed substance for the purpose of preparing and self-administering it, and
(c) prepare the prescribed substance, and
(d) self-administer the prescribed substance.
(6) The contact person for the patient is authorised as set out in section 68(1).
(7) An agent of the patient is authorised to—
(a) receive the prescribed substance from an authorised supplier, and
(b) possess the prescribed substance for the purpose of supplying the substance to the patient, and
(c) prepare the prescribed substance for self-administration by the patient, and
(d) supply the prescribed substance to the patient.
60
Practitioner administration
60 Practitioner administration
60 Practitioner administration
(1) This section applies if the patient—
(a) has made a practitioner administration decision, and
(b) has not revoked the decision.
(2) The coordinating practitioner for the patient is authorised to prescribe a voluntary assisted dying substance for the patient that is of a sufficient dose to cause death.
(3) To avoid doubt, subsection (2) is subject to the Board having granted a voluntary assisted dying substance authority under section 71 in relation to the patient.
(4) The authorised supplier who is given the prescription for the patient is authorised to—
(a) possess the prescribed substance for the purpose of preparing and supplying the substance to the administering practitioner for the patient, and
(b) prepare the prescribed substance, and
(c) supply the prescribed substance to the administering practitioner for the patient.
(5) The administering practitioner for the patient is authorised to—
(a) receive the prescribed substance from an authorised supplier, and
(b) possess the prescribed substance for the purpose of preparing and administering the substance to the patient, and
(c) prepare the prescribed substance.
(6) The administering practitioner for the patient is authorised, in the presence of a witness, to administer the prescribed substance to the patient if the administering practitioner is satisfied at the time of administration that—
(a) the patient has decision-making capacity in relation to voluntary assisted dying, and
(b) the patient is acting voluntarily, and
(c) the patient is not acting because of pressure or duress, and
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(d) the patient’s request for access to voluntary assisted dying is enduring.
61
Coordinating practitioner to notify Board about prescription of substance
61 Coordinating practitioner to notify Board about prescription of substance
61 Coordinating practitioner to notify Board about prescription of substance
(1) Within 5 business days after prescribing a voluntary assisted dying substance for the patient, the patient’s coordinating practitioner must—
(a) complete the approved form for the prescription of the voluntary assisted dying substance (the prescription form) including the information required by subsection (2), and
(b) give the Board a copy of the prescription form.
Maximum penalty—100 penalty units.
(2) The prescription form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the coordinating practitioner’s name and contact details,
(c) a statement confirming the coordinating practitioner has complied with section 73(2) or (3),
(d) the date the prescription for the voluntary assisted dying substance was issued,
(e) the coordinating practitioner’s name and the date the form was signed.
62
Certification by administering practitioner following administration of prescribed substance
62 Certification by administering practitioner following administration of prescribed substance
62 Certification by administering practitioner following administration of prescribed substance
(1) This section applies if the patient’s administering practitioner administers the prescribed substance to the patient.
(2) The administering practitioner must certify in writing that—
(a) the patient made a practitioner administration decision and did not revoke the decision, and
(b) the administering practitioner was satisfied when administering the prescribed substance to the patient that—
(i) the patient had decision-making capacity in relation to voluntary assisted dying, and
(ii) the patient was acting voluntarily, and
(iii) the patient was not acting because of pressure or duress, and
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(iv) the patient’s request for access to voluntary assisted dying was enduring.
(3) The certification must be in the approved form (the practitioner administration form) and must include the following—
(a) the patient’s name and date of birth,
(b) the administering practitioner’s name and contact details,
(c) the name, date of birth and contact details of the witness to the administration of the prescribed substance,
(d) the date and time the prescribed substance was administered,
(e) the location at which the prescribed substance was administered,
(f) the date and time of the patient’s death,
(g) the period of time that elapsed between the administration of the prescribed substance and the patient’s death,
(h) details of any complications relating to the administration of the prescribed substance,
(i) the witness’ certification required under section 63(3),
(j) the administering practitioner’s signature and the date the form was signed,
(k) the witness’s signature and the date the form was signed.
(4) Within 5 business days after administering the prescribed substance, the administering practitioner must give a copy of the practitioner administration form to the Board.
Maximum penalty—100 penalty units.
63
Witness to administration of prescribed substance
63 Witness to administration of prescribed substance
63 Witness to administration of prescribed substance
(1) For the purposes of section 60(6), a person is eligible to witness the administration of a prescribed substance to a patient if the person—
(a) is an adult, and
(b) is not an ineligible witness.
(2) For the purposes of subsection (1)(b), a person is an ineligible witness if the person—
(a) is a family member of the patient’s administering practitioner, or
(b) is employed, or engaged under a contract for services, by the patient’s administering practitioner.
(3) The witness to the administration of a prescribed substance to a patient must certify in the practitioner administration form for the patient that—
(a) the patient’s request for access to voluntary assisted dying appeared to be free, voluntary and enduring, and
(b) the patient’s administering practitioner administered the prescribed substance to the patient in the presence of the witness.
64
Transfer of administering practitioner’s role
64 Transfer of administering practitioner’s role
64 Transfer of administering practitioner’s role
(1) This section applies if—
(a) a patient has made a practitioner administration decision, and
(b) the coordinating practitioner for the patient has prescribed a voluntary assisted dying substance for the patient, and
(c) the patient’s administering practitioner (the original practitioner) is unable or unwilling for any reason to administer the prescribed substance to the patient, whether the original practitioner is—
(i) the coordinating practitioner for the patient, or
(ii) a person to whom the role of administering practitioner has been transferred under subsection (2).
(2) The original practitioner must transfer the role of administering practitioner to another person who—
(a) is eligible to act as an administering practitioner for the patient, and
(b) accepts the transfer of the role.
(3) If a person (the new practitioner) accepts the transfer of the role, the original practitioner must—
(a) inform the patient—
(i) that the role of administering practitioner has been transferred to the new practitioner, and
(ii) of the new practitioner’s name and contact details, and
(b) record the transfer in the patient’s medical record, and
(c) within 5 business days after the transfer is accepted, complete the approved form (the administering practitioner transfer form) and give a copy of the form to the Board.
Maximum penalty—100 penalty units.
(4) The administering practitioner transfer form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the original practitioner’s name and contact details,
(c) the new practitioner’s name and contact details,
(d) the date the new practitioner accepted the transfer,
(e) the date the patient was informed of the transfer,
(f) the original practitioner’s signature and the date the form was signed.
(5) If the original practitioner has possession of the prescribed substance when the role is transferred—
(a) the original practitioner is authorised to supply the prescribed substance to the new practitioner, and
(b) the new practitioner is authorised to receive the prescribed substance from the original practitioner.
(6) The coordinating practitioner for the patient remains the coordinating practitioner despite any transfer of the role of administering practitioner under subsection (2), but subject to section 175.
65
Application of Division
65 Application of Division
65 Application of Division
This Division applies if a patient has made a self-administration decision.
66
Patient to appoint contact person
66 Patient to appoint contact person
66 Patient to appoint contact person
(1) The patient must appoint a person as the patient’s contact person.
(2) A person is eligible for appointment if the person is an adult.
(3) Without limiting who may be appointed as the contact person, the patient may appoint—
(a) the patient’s coordinating practitioner, or
(b) the patient’s consulting practitioner, or
(c) another registered health practitioner.
(4) A person must not be appointed as the contact person unless the person consents to the appointment.
(5) The patient may revoke the appointment of the contact person.
(6) If the patient revokes the appointment of the contact person—
(a) the patient must inform the person of the revocation, and
(b) the person ceases to be the contact person for the patient on being informed under paragraph (a), and
(c) the patient must make another appointment under subsection (1).
67
Contact person appointment form
67 Contact person appointment form
67 Contact person appointment form
(1) The appointment of a contact person by the patient must be made in the approved form (the contact person appointment form) and include the following—
(a) the patient’s name, date of birth and contact details,
(b) the name and contact details of the coordinating practitioner for the patient,
(c) the contact person’s name, date of birth and contact details,
(d) a statement that the contact person consents to the appointment,
(e) a statement that the contact person understands the person’s role under this Act, including—
(i) that the contact person agrees to comply with guidelines issued by the Health Secretary under section 181(2)(d), and
(ii) the requirements under section 125 and the penalties for contravening the requirements,
(f) if the patient was assisted by an interpreter when making the appointment, the interpreter’s name, contact details and accreditation details,
(g) the contact person’s signature and the date the form was signed,
(h) the patient’s signature, or the signature of the other person who completes the form on behalf of the patient, and the date the form was signed.
(2) Another person may complete the form on behalf of the patient if—
(a) the patient is unable to complete the contact person appointment form, and
(b) the patient directs the person to complete the contact person appointment form, and
(c) the person is an adult.
(3) The patient or the patient’s contact person must give the contact person appointment form to the patient’s coordinating practitioner.
(4) Within 5 business days after receiving the contact person appointment form, the patient’s coordinating practitioner must give a copy of the form to the Board.
Maximum penalty—100 penalty units.
(5) The patient’s coordinating practitioner must not prescribe a voluntary assisted dying substance for the patient before the contact person appointment form is given to the coordinating practitioner.
68
Role of contact person
68 Role of contact person
68 Role of contact person
(1) The contact person for the patient is authorised to—
(a) receive the prescribed substance from an authorised supplier, and
(b) possess the prescribed substance for the purposes of paragraphs (c)–(e), and
(c) prepare the prescribed substance for self-administration by the patient, and
(d) supply the prescribed substance to the patient, and
(e) give the prescribed substance, or any unused or remaining prescribed substance, to an authorised disposer as required by section 125.
(2) The patient’s contact person must inform the patient’s coordinating practitioner if the patient dies, whether as a result of self-administering the prescribed substance or from some other cause.
69
Contact person may refuse to continue in role
69 Contact person may refuse to continue in role
69 Contact person may refuse to continue in role
(1) The contact person for a patient may refuse to continue to perform the role of contact person.
(2) If the contact person for a patient refuses to continue to perform the role—
(a) the person must inform the patient of the refusal, and
(b) the person ceases to be the contact person for the patient on informing the patient under paragraph (a), and
(c) the patient must make another appointment under section 66(1).
70
Coordinating practitioner may ask Board to issue voluntary assisted dying substance authorisation
70 Coordinating practitioner may ask Board to issue voluntary assisted dying substance authorisation
70 Coordinating practitioner may ask Board to issue voluntary assisted dying substance authorisation
(1) If a patient has made an administration decision, the patient’s coordinating practitioner may apply to the Board for a voluntary assisted dying substance authorisation for the patient.
(2) The application must be—
(a) in the approved form, and
(b) accompanied by the documents relating to the request and assessment process required by the Board.
71
Board must decide application
71 Board must decide application
71 Board must decide application
(1) As soon as practicable after receiving an application for a voluntary assisted dying substance authorisation from the patient’s coordinating practitioner, the Board must—
(a) consider the application, and
(b) decide to—
(i) approve the application, or
(ii) if section 72 applies—refuse the application.
(2) If the Board decides to approve the application, the Board must, as soon as practicable after making the decision, grant a voluntary assisted dying substance authority, in the approved form, in relation to the patient.
(3) A voluntary assisted dying substance authority must include the following information—
(a) the patient’s name and address,
(b) the name of the patient’s coordinating practitioner,
(c) the period during which the patient’s coordinating practitioner may prescribe a prescribed substance under the authority,
(d) other information required by the Health Secretary.
(4) A voluntary assisted dying substance authority may relate to a voluntary assisted dying substance that may be self-administered or administered to a person.
72
Refusal of application for voluntary assisted dying substance authority
72 Refusal of application for voluntary assisted dying substance authority
72 Refusal of application for voluntary assisted dying substance authority
(1) The Board must refuse to issue to a patient’s coordinating practitioner a voluntary assisted dying substance authority in relation to the patient if—
(a) the Board has not received all the documents relating to the request and assessment process required under section 70(2)(b), or
(b) the Board suspects the requirements of this Act have not been met in relation to the patient.
(2) If the Board refuses an application for a voluntary assisted dying substance authority, the Board must, within 2 business days, give the patient’s coordinating practitioner written notice that states—
(a) the application has been refused, and
(b) the reasons for the refusal.
73
Information to be given before prescribing substance
73 Information to be given before prescribing substance
73 Information to be given before prescribing substance
(1) This section applies if—
(a) a patient has made an administration decision, and
(b) the Board has issued a voluntary assisted dying substance authority in relation to the patient.
(2) The patient’s coordinating practitioner must, if the patient has made a self-administration decision, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following—
(a) the Schedule 4 poison or Schedule 8 poison, or combination of poisons, constituting the substance,
(b) that the patient is not under an obligation to obtain the substance,
(c) that the patient is not under an obligation to self-administer the substance,
(d) how to dispense the substance,
(e) that the substance must be stored—
(i) in a locked box that complies with the requirements stated in section 79, and
(ii) otherwise in accordance with the information provided by the authorised supplier who supplies the substance,
(f) how to prepare and self-administer the substance,
(g) the method by which the substance will be self-administered,
(h) the expected effects of self-administration of the substance,
(i) the period within which the patient is likely to die after self-administration of the substance,
(j) the potential risks of self-administration of the substance,
(k) that, if the patient decides not to self administer the substance, the patient’s contact person must give the substance to an authorised disposer for disposal,
(l) that, if the patient dies, the patient’s contact person must give any unused or remaining substance to an authorised disposer for disposal.
(3) The coordinating practitioner for a patient who has made a practitioner administration decision must, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following—
(a) the Schedule 4 poison or Schedule 8 poison, or combination of poisons, constituting the substance,
(b) that the patient is not under an obligation to have the substance administered,
(c) how the substance will be dispensed,
(d) the method by which the substance will be administered,
(e) the expected effects of administration of the substance,
(f) the period within which the patient is likely to die after administration of the substance,
(g) the potential risks of administration of the substance,
(h) that, if the practitioner administration decision is made after the revocation of a self-administration decision, the patient’s contact person must give any prescribed substance received by the patient, the contact person or an agent of the patient, to an authorised disposer for disposal.
74
Prescription for substance
74 Prescription for substance
74 Prescription for substance
(1) This section applies if a patient’s coordinating practitioner prescribes a voluntary assisted dying substance for the patient.
Note—
(2) The prescription issued by the coordinating practitioner must include—
(a) a statement that clearly indicates the prescription is for a voluntary assisted dying substance, and
(b) a statement—
(i) certifying that the request and assessment process has been completed in relation to the patient in accordance with this Act, and
(ii) certifying that the patient has made an administration decision and stating whether the decision is a self-administration decision or a practitioner administration decision, and
(c) the patient’s telephone number.
(3) The prescription must not be in the form of a medication chart.
(4) The prescription must not provide for the prescribed substance to be supplied on more than 1 occasion.
(5) The coordinating practitioner must give the prescription directly to an authorised supplier.
(6) To avoid doubt, the requirement under subsection (5) to give the prescription directly to an authorised supplier does not require the prescription to be given to the authorised supplier in person but may be given by post or electronic means, including email.
(7) In this section—
medication chart means a chart, however described, that records medicines used, or to be used, for the treatment of a patient.
75
Authorised supplier to authenticate prescription
75 Authorised supplier to authenticate prescription
75 Authorised supplier to authenticate prescription
An authorised supplier who is given a prescription for a voluntary assisted dying substance must not supply the substance in accordance with the prescription unless the authorised supplier has confirmed—
(a) the authenticity of the prescription, and
(b) the identity of the person who issued the prescription, and
(c) the identity of the person to whom the substance is to be supplied.
76
Information to be given when supplying prescribed substance
76 Information to be given when supplying prescribed substance
76 Information to be given when supplying prescribed substance
(1) This section applies if an authorised supplier supplies a prescribed substance to a patient, a patient’s contact person or an agent of a patient (the recipient).
(2) The authorised supplier must, when supplying the prescribed substance, inform the recipient, in writing, of the following—
(a) that the patient is not under an obligation to self-administer the substance,
(b) that the substance must be stored—
(i) in a locked box that complies with the requirements stated in section 79, and
(ii) otherwise in accordance with other requirements provided by the authorised supplier,
(c) how to prepare and self-administer the substance,
(d) that, if the patient decides not to self-administer the substance, the patient’s contact person must give the substance to an authorised disposer for disposal,
(e) that, if the patient dies, the patient’s contact person must give any unused or remaining substance to an authorised disposer for disposal not later than 14 days after the day on which the patient dies,
(f) details of the place where any unused or remaining substance may be given to an authorised disposer for disposal.
(3) If the recipient is not the patient, the authorised supplier must, when supplying the prescribed substance, advise the recipient to give the information given under subsection (2) to the patient.
77
Labelling requirements for prescribed substance
77 Labelling requirements for prescribed substance
77 Labelling requirements for prescribed substance
(1) In addition to labelling requirements under the Poisons and Therapeutic Goods Act 1966, an authorised supplier who supplies a prescribed substance must attach a statement in writing to the relevant package or container that—
(a) warns of the purpose of the dose of the substance, and
(b) states the dangers of administration of the substance, and
(c) states that, if the substance is supplied for self-administration—
(i) the substance must be stored—
(A) in a locked box that complies with the requirements stated in section 79, and
(B) otherwise in accordance with other requirements provided by the authorised supplier, and
(ii) any unused or remaining substance must be given to an authorised disposer by the contact person for the patient to whom the substance is supplied.
(2) The statement must be in the approved form.
78
Authorised supplier to record and notify of supply
78 Authorised supplier to record and notify of supply
78 Authorised supplier to record and notify of supply
(1) An authorised supplier who supplies a prescribed substance must immediately complete the approved form (the authorised supply form).
(2) The authorised supply form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the authorised supplier’s name and contact details,
(c) a statement certifying that the prescribed substance was supplied,
(d) the name and contact details of the person to whom the prescribed substance was supplied,
(e) the date the prescribed substance was supplied,
(f) a statement certifying that the requirements under sections 75, 76 and 77 were complied with,
(g) the authorised supplier’s signature and the date the form was signed.
(3) Within 5 business days after supplying the prescribed substance, the authorised supplier must give a copy of the completed authorised supply form to the Board.
Maximum penalty—100 penalty units.
79
Storage of voluntary assisted dying substance
79 Storage of voluntary assisted dying substance
79 Storage of voluntary assisted dying substance
(1) A person who receives a voluntary assisted dying substance must store the substance in a locked box.
(2) The locked box must be—
(a) made of steel, and
(b) not easily penetrable, and
(c) locked using a lock of sturdy construction.
80
Disposal of prescribed substance by authorised disposer
80 Disposal of prescribed substance by authorised disposer
80 Disposal of prescribed substance by authorised disposer
(1) This section applies if a prescribed substance, or any unused or remaining prescribed substance, is given to an authorised disposer by the patient’s contact person.
(2) The authorised disposer is authorised to—
(a) possess the prescribed substance for the purpose of disposing of it, and
(b) dispose of the prescribed substance.
(3) The authorised disposer must dispose of the prescribed substance as soon as practicable after receiving it.
(4) In disposing of the prescribed substance, the authorised disposer must comply with requirements of the Poisons and Therapeutic Goods Act 1966 that apply to the disposal.
81
Authorised disposer to record and notify of disposal
81 Authorised disposer to record and notify of disposal
81 Authorised disposer to record and notify of disposal
(1) An authorised disposer who disposes of a prescribed substance must immediately complete the approved form (the authorised disposal form).
(2) The authorised disposal form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the authorised disposer’s name and contact details,
(c) the name and contact details of the person who gave the prescribed substance to the authorised disposer,
(d) the date the prescribed substance was given to the authorised disposer,
(e) the date the prescribed substance was disposed of by the authorised disposer,
(f) the authorised disposer’s signature and the date the form was signed.
(3) Within 5 business days after disposing of the prescribed substance, the authorised disposer must give a copy of the completed authorised disposal form to the Board.
Maximum penalty—100 penalty units.
82
Disposal of prescribed substance by administering practitioner
82 Disposal of prescribed substance by administering practitioner
82 Disposal of prescribed substance by administering practitioner
(1) Subsections (2) and (3) apply if—
(a) a patient who has made a practitioner administration decision revokes the decision, and
(b) the administering practitioner for the patient has possession of the prescribed substance when the decision is revoked.
(2) The administering practitioner is authorised to—
(a) possess the prescribed substance for the purpose of disposing of it, and
(b) dispose of the prescribed substance.
(3) The prescribed substance must be disposed of by the administering practitioner as soon as practicable after the practitioner administration decision is revoked.
(4) Subsections (5) and (6) apply if—
(a) a patient who has made a practitioner administration decision dies, whether or not after being administered the prescribed substance, and
(b) the patient’s administering practitioner has possession of any prescribed substance that is unused or remaining after the patient’s death (the unused or remaining substance).
(5) The administering practitioner is authorised to—
(a) possess the unused or remaining substance for the purpose of disposing of it, and
(b) dispose of the unused or remaining substance.
(6) The unused or remaining substance must be disposed of by the administering practitioner as soon as practicable after the patient’s death.
(7) In disposing of the prescribed substance or the unused or remaining substance, as the case requires, the administering practitioner must comply with requirements of the Poisons and Therapeutic Goods Act 1966 that apply to the disposal.
83
Administering practitioner to record and notify of disposal
83 Administering practitioner to record and notify of disposal
83 Administering practitioner to record and notify of disposal
(1) A patient’s administering practitioner who disposes of a prescribed substance must immediately complete the approved form (the practitioner disposal form).
(2) The practitioner disposal form must include the following—
(a) the patient’s name, date of birth and contact details,
(b) the administering practitioner’s name and contact details,
(c) the date the prescribed substance was supplied to the administering practitioner,
(d) the date the patient revoked the practitioner administration decision or died,
(e) the date the prescribed substance was disposed of by the administering practitioner,
(f) the administering practitioner’s signature and the date the form was signed.
(3) Within 5 business days after disposing of the prescribed substance, the administering practitioner must give a copy of the completed practitioner disposal form to the Board.
Maximum penalty—100 penalty units.
84
Authorised suppliers and authorised disposers
84 Authorised suppliers and authorised disposers
84 Authorised suppliers and authorised disposers
(1) The Health Secretary may, by Gazette notice, authorise a registered health practitioner, or persons in a class of registered health practitioners, to supply prescribed substances for the purposes of this Part.
(2) A person who is authorised under subsection (1) is an authorised supplier.
(3) The Health Secretary may, by Gazette notice, authorise a registered health practitioner, or persons in a class of registered health practitioners, to dispose of prescribed substances for the purposes of this Part.
(4) A person who is authorised under subsection (3) is also an authorised disposer.
(5) The Health Secretary may, by Gazette notice, revoke an authorisation given under subsection (1) or (3).
(6) The Health Secretary must keep a register that includes details of—
(a) authorised suppliers, and
(b) authorised disposers.
(7) The register kept under subsection (6) may only be made available for inspection by a person who is—
(a) a patient, or
(b) a contact person or an agent of a patient, or
(c) a coordinating practitioner, or
(d) a consulting practitioner, or
(e) an administering practitioner, or
(f) a person performing functions under this Act, for the purposes of performing the functions.
85
Certain directions as to supply or administration prohibited
85 Certain directions as to supply or administration prohibited
85 Certain directions as to supply or administration prohibited
(1) A patient’s coordinating practitioner must not direct a health professional to supply a prescribed substance to the patient, the contact person for the patient or an agent of the patient, unless—
(a) the health professional is an authorised supplier, and
(b) the direction is in the form of a prescription for the prescribed substance given directly to the authorised supplier.
(2) A patient’s coordinating practitioner or administering practitioner must not direct a health professional to administer a prescribed substance to the patient.
86
Structured administration and supply arrangement not to be issued for substance
86 Structured administration and supply arrangement not to be issued for substance
86 Structured administration and supply arrangement not to be issued for substance
(1) A person must not issue a structured administration and supply arrangement in relation to the administration or supply of a medicine for the purpose of voluntary assisted dying.
(2) In this section—
structured administration and supply arrangement means a document that sets out the circumstances in which a health professional stated, or of a class stated, in the document may administer or supply a medicine stated in the document.
87
Notification of death
87 Notification of death
87 Notification of death
(1) A patient’s coordinating practitioner or administering practitioner must, within 5 business days after becoming aware the patient has died, notify the Board, in the approved form, of the patient’s death.
Maximum penalty—100 penalty units.
(2) Subsection (1) applies whether or not the patient dies after self-administering, or being administered, a voluntary assisted dying substance in accordance with this Act.
(3) Subsection (1) does not apply if the administering practitioner for a patient gives the Board a copy of a practitioner administration form in relation to the patient under section 62(4).
(4) Subsections (5) and (6) apply if a medical practitioner who is required to give a cause of death certificate for a person knows or reasonably believes the person was a patient who self-administered, or was administered, a voluntary assisted dying substance in accordance with this Act.
(5) The medical practitioner must, within 5 business days after becoming aware the person has died, notify the Board, in the approved form, of the person’s death unless the medical practitioner is the person’s coordinating practitioner or administering practitioner.
(6) The medical practitioner must identify the following in the cause of death certificate for the person—
(a) that the medical practitioner knows or reasonably believes the patient self-administered, or was administered, a voluntary assisted dying substance in accordance with this Act,
(b) the disease, illness or medical condition with which the person had been diagnosed that made the person eligible to access voluntary assisted dying.
health entity means an entity that owns or operates a health care establishment.
relevant entity means an entity, other than an individual, that provides a relevant service.
relevant service means—
(a) a personal care service, or
(b) a residential aged care service.
residential aged care means nursing care or personal care provided to a person in a residential facility in which the person is also provided with accommodation that includes—
(a) staffing to meet the nursing care and personal care needs of the person, and
(b) meals and cleaning services, and
(c) furnishings, furniture and equipment for the provision of the person’s nursing care or personal care and accommodation.
89
Participation in providing voluntary assisted dying services
89 Participation in providing voluntary assisted dying services
89 Participation in providing voluntary assisted dying services
(1) A residential facility or health care establishment may decide that it will not provide services relating to voluntary assisted dying at the facility or establishment.
(2) For the purposes of subsection (1), the residential facility or health care establishment may refuse to do any of the following or refuse to have persons employed by or at the facility or establishment do any of the following at the facility or establishment—
(a) participate in the request and assessment process,
(b) participate in an administration decision,
(c) prescribe, supply or administer a voluntary assisted dying substance,
(d) store a voluntary assisted dying substance,
(e) be present at the time of the administration or self-administration of a voluntary assisted dying substance.
(3) Subsections (1) and (2) are subject to the requirements of Divisions 2 and 3.
pt.5-div.2-sdiv.1
Information about voluntary assisted dying
pt.5-div.2-sdiv.1 Information about voluntary assisted dying
Subdivision 1 Information about voluntary assisted dying
90
Access to information about voluntary assisted dying
90 Access to information about voluntary assisted dying
90 Access to information about voluntary assisted dying
(1) This section applies if—
(a) a person is receiving relevant services from a relevant entity at a residential facility, and
(b) the person asks the relevant entity for information about voluntary assisted dying, and
(c) the relevant entity does not provide at the residential facility, to persons to whom relevant services are provided, the information that has been requested.
(2) The relevant entity and any other entity that owns or occupies the residential facility—
(a) must not hinder the person’s access at the residential facility to information about voluntary assisted dying, and
(b) must, if asked, allow reasonable access to the person at the residential facility by—
(i) a registered health practitioner or another person to enable the practitioner or other person to personally provide the requested information about voluntary assisted dying to the person, or
(ii) a member of an official voluntary assisted dying care navigator service to provide support, assistance and information to persons relating to voluntary assisted dying.
pt.5-div.2-sdiv.2
Access to voluntary assisted dying
pt.5-div.2-sdiv.2 Access to voluntary assisted dying
Subdivision 2 Access to voluntary assisted dying
91
Application of Subdivision
91 Application of Subdivision
91 Application of Subdivision
This Subdivision applies if a person is receiving relevant services from a relevant entity at a residential facility.
92
First and final requests
92 First and final requests
92 First and final requests
(1) This section applies if—
(a) the person or the person’s agent advises the relevant entity that the person wishes to make a first request or final request (each a relevant request), and
(b) the relevant entity does not provide, to persons to whom relevant services are provided at the residential facility, access to the request and assessment process at the facility.
(2) The relevant entity and any other entity that owns or occupies the facility must allow reasonable access to the person at the residential facility by a medical practitioner—
(a) whose presence is requested by the person, and
(b) who—
(i) for a first request—is eligible to act as a coordinating practitioner, or
(ii) for a final request—is the coordinating practitioner for the person.
(3) If the requested medical practitioner is not available to attend, the relevant entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s relevant request may be made to—
(a) the requested medical practitioner, or
(b) another medical practitioner who is eligible and willing to act as a coordinating practitioner.
93
First assessments
93 First assessments
93 First assessments
(1) This section applies if—
(a) the person has made a first request, and
(b) the person, or the person’s agent, advises the relevant entity that the person wishes to undergo a first assessment, and
(c) the relevant entity does not provide, to persons to whom relevant services are provided at the residential facility, access to the request and assessment process at the facility.
(2) If the person is a permanent resident at the residential facility—
(a) the relevant entity and any other entity that owns or occupies the residential facility must allow reasonable access to the person at the facility by a relevant practitioner for the practitioner to assess the person, and
(b) if a relevant practitioner is not available to attend—the relevant entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s assessment may be carried out by—
(i) the relevant practitioner, or
(ii) another medical practitioner who is eligible and willing to act as a relevant practitioner.
(3) If the person is not a permanent resident at the residential facility—
(a) the relevant entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s first assessment may be carried out by a relevant practitioner for the person, or
(b) if, in the deciding practitioner’s opinion, transfer of the person as described in paragraph (a) would not be reasonable in the circumstances—the relevant entity and any other entity that owns or occupies the residential facility must allow reasonable access to the person at the facility by a relevant practitioner for the person.
(4) In making a decision for subsection (3)(b), the deciding practitioner must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
(5) In this section—
relevant practitioner, for a person, means—
(a) the person’s coordinating practitioner, or
(b) a medical practitioner to whom the person’s coordinating practitioner has referred a matter under section 26.
94
Consulting assessments
94 Consulting assessments
94 Consulting assessments
(1) This section applies if—
(a) the person has undergone a first assessment, and
(b) the person, or the person’s agent, advises the relevant entity that the person wishes to undergo a consulting assessment, and
(c) the entity does not provide, to persons to whom the relevant services are provided at the residential facility, access to the request and assessment process at the facility.
(2) If the person is a permanent resident at the residential facility—
(a) the relevant entity and any other entity that owns or occupies the residential facility must allow reasonable access to the person at the facility by a relevant practitioner for the practitioner to assess the person, and
(b) if a relevant practitioner is not available to attend—the relevant entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s assessment may be carried out by—
(i) the relevant practitioner, or
(ii) another medical practitioner who is eligible and willing to act as a relevant practitioner.
(3) If the person is not a permanent resident at the residential facility—
(a) the relevant entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s first assessment may be carried out by a relevant practitioner for the person, or
(b) if, in the deciding practitioner’s opinion, transfer of the person as described in paragraph (a) would not be reasonable in the circumstances—the relevant entity and any other entity that owns or occupies the residential facility must allow reasonable access to the person at the facility by a relevant practitioner for the person.
(4) In making a decision for subsection (3)(b), the deciding practitioner must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
(5) In this section—
relevant practitioner, for a person, means—
(a) the person’s consulting practitioner, or
(b) a medical practitioner to whom the person’s consulting practitioner has referred a matter under section 37.
95
Written declarations
95 Written declarations
95 Written declarations
(1) This section applies if—
(a) the person has been assessed as eligible for access to voluntary assisted dying, and
(b) the person or the person’s agent advises the relevant entity that the person wishes to make a written declaration, and
(c) the entity does not provide, to persons to whom relevant services are provided at the residential premises, access to the request and assessment process at the facility.
(2) If the person is a permanent resident at the residential facility—
(a) the relevant entity and any other entity that owns or occupies the residential facility must allow reasonable access to the person at the facility by—
(i) the person’s coordinating practitioner, and
(ii) another person lawfully participating in the person’s request for access to voluntary assisted dying to enable the person to make a written declaration, and
(b) if the coordinating practitioner is not available to attend—the relevant entity must take reasonable steps to facilitate the transfer of the person to and from the place where the person may make a written declaration.
(3) If the person is not a permanent resident at the residential facility—
(a) the relevant entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person may make a written declaration, or
(b) if, in the deciding practitioner’s opinion, transfer of the person as described in paragraph (a) would not be reasonable in the circumstances—the entity and any other entity that owns or occupies the residential facility must allow reasonable access to the person at the facility by—
(i) the person’s coordinating practitioner, and
(ii) any other person lawfully participating in the person’s request for access to voluntary assisted dying.
(4) In making a decision for subsection (3)(b), the deciding practitioner must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
96
Application for administration decision
96 Application for administration decision
96 Application for administration decision
(1) This section applies if—
(a) the person has made a final request, and
(b) the person or the person’s agent advises the relevant entity that the person wishes to make an application for an administration decision, and
(c) the entity does not provide, to persons to whom relevant services are provided at the residential facility, access to a person’s coordinating practitioner to enable the application to be made.
(2) If the person is a permanent resident at the residential facility—
(a) the relevant entity and any other entity that owns or occupies the facility must allow reasonable access to the person at the facility by the person’s coordinating practitioner for the practitioner to consult with and assess the person in relation to the application, and
(b) if the coordinating practitioner is not available to attend—the relevant entity must take reasonable steps to facilitate the transfer of the person to and from a place where consultation and assessment of the person can occur in relation to the application in consultation with, and on the advice of—
(i) the coordinating practitioner, or
(ii) another medical practitioner who is eligible and willing to act as the person’s coordinating practitioner.
(3) If the person is not a permanent resident at the residential facility—
(a) the relevant entity must take reasonable steps to facilitate the transfer of the person to and from the place where the person’s coordinating practitioner can consult with and assess the person in relation to the application, or
(b) if, in the deciding practitioner’s opinion, transfer of the person as described in paragraph (a) would not be reasonable in the circumstances—the relevant entity and any other entity that owns or occupies the residential facility must allow reasonable access to the person at the facility by the person’s coordinating practitioner to consult with and assess the person in relation to the application.
(4) In making a decision for subsection (3)(b), the deciding practitioner must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
pt.5-div.2-sdiv.3
Administration of voluntary assisted dying substance
pt.5-div.2-sdiv.3 Administration of voluntary assisted dying substance
Subdivision 3 Administration of voluntary assisted dying substance
97
Administration of voluntary assisted dying substance
97 Administration of voluntary assisted dying substance
97 Administration of voluntary assisted dying substance
(1) This section applies if—
(a) the person has made an administration decision, and
(b) the person or the person’s agent advises the relevant entity that the person wishes to self-administer a voluntary assisted dying substance or have the person’s administering practitioner administer a voluntary assisted dying substance to the person, and
(c) the relevant entity does not provide, to persons to whom relevant services are provided at the residential facility, access to the administration of a voluntary assisted dying substance at the facility.
(2) If the person is a permanent resident at the residential facility, the relevant entity and any other entity that owns or occupies the facility must—
(a) if the person has made a practitioner administration decision—allow reasonable access to the person at the facility by the following persons—
(i) the person’s administering practitioner, for the practitioner to administer a voluntary assisted dying substance to the person,
(ii) any other person lawfully participating in the person’s request for access to voluntary assisted dying, including an eligible witness to the administration of the voluntary assisted dying substance by the person’s administering practitioner, or
(b) if the person has made a self-administration decision—
(i) allow reasonable access to the person at the facility by a person lawfully delivering a voluntary assisted dying substance to the person, and
(ii) allow reasonable access to the person at the facility by another person lawfully participating in the person’s request for voluntary assisted dying, and
(iii) not otherwise hinder access by the person to a voluntary assisted dying substance.
(3) If the person is not a permanent resident at the residential facility—
(a) the relevant entity must take reasonable steps to facilitate the transfer of the person to a place where the person may be administered or may self-administer a voluntary assisted dying substance, or
(b) if, in the deciding practitioner’s opinion, transfer of the person as described in paragraph (a) would not be reasonable in the circumstances—subsection (2) applies in relation to the person as if the person were a permanent resident at the residential facility.
(4) In making a decision for subsection (3)(b), the deciding practitioner must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
pt.5-div.2-sdiv.4
Information about non-availability of voluntary assisted dying
pt.5-div.2-sdiv.4 Information about non-availability of voluntary assisted dying
Subdivision 4 Information about non-availability of voluntary assisted dying
98
Relevant entities to inform public about non-availability of voluntary assisted dying
98 Relevant entities to inform public about non-availability of voluntary assisted dying
98 Relevant entities to inform public about non-availability of voluntary assisted dying
(1) This section applies to a relevant entity that does not provide, at a residential facility at which the entity provides relevant services, services associated with voluntary assisted dying, including access to the request and assessment process or access to the administration of a voluntary assisted dying substance.
(2) The relevant entity must publish information about the fact the entity does not provide any services, or services of a specified type, associated with voluntary assisted dying at the residential facility.
(3) The relevant entity must publish the information in a way in which it is likely that persons who receive the services of the entity at the residential facility become aware of the information.
pt.5-div.3-sdiv.1
Information about voluntary assisted dying
pt.5-div.3-sdiv.1 Information about voluntary assisted dying
Subdivision 1 Information about voluntary assisted dying
99
Access to information about voluntary assisted dying
99 Access to information about voluntary assisted dying
99 Access to information about voluntary assisted dying
(1) This section applies if—
(a) a person is receiving health care from a health entity at a health establishment, and
(b) the person asks the health entity for information about voluntary assisted dying, and
(c) the health entity does not provide at the health establishment, to persons to whom health care is provided, the information that has been requested.
(2) The health entity—
(a) must not hinder the person’s access at the health establishment to information about voluntary assisted dying, and
(b) must, if asked, allow reasonable access to the person at the health establishment by a member of an official voluntary assisted dying care navigator service to provide support, assistance and information to persons relating to voluntary assisted dying.
pt.5-div.3-sdiv.2
Access to voluntary assisted dying
pt.5-div.3-sdiv.2 Access to voluntary assisted dying
Subdivision 2 Access to voluntary assisted dying
100
Application of Subdivision
100 Application of Subdivision
100 Application of Subdivision
This Subdivision applies if a person is receiving health care from a health entity at a health establishment.
101
First and final requests
101 First and final requests
101 First and final requests
(1) This section applies if—
(a) the person or the person’s agent advises the health entity that the person wishes to make a first request or final request (each a relevant request), and
(b) the health entity does not provide, to persons to whom health care is provided at the health care establishment, access to the request and assessment process at the establishment.
(2) The health entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s relevant request may be made to—
(a) a medical practitioner requested by the person who—
(i) for a first request—is eligible to act as a coordinating practitioner, or
(ii) for a final request—is the person’s coordinating practitioner, or
(b) if the requested medical practitioner is not available—another medical practitioner who is eligible and willing to act as a coordinating practitioner for the person.
102
First assessments
102 First assessments
102 First assessments
(1) This section applies if—
(a) the person has made a first request, and
(b) the person, or the person’s agent, advises the health entity that the person wishes to undergo a first assessment, and
(c) the health entity does not provide, to persons to whom health care is provided at the health establishment, access to the request and assessment process at the facility.
(2) The health entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s first assessment may be carried out by a relevant practitioner for the person.
(3) In making a decision under subsection (2) about the reasonable steps that may be taken to facilitate the transfer of the person, the health entity must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
(4) In this section—
relevant practitioner, for a person, means—
(a) the person’s coordinating practitioner, or
(b) a medical practitioner to whom the person’s coordinating practitioner has referred a matter under section 26.
103
Consulting assessments
103 Consulting assessments
103 Consulting assessments
(1) This section applies if—
(a) the person has undergone a first assessment, and
(b) the person, or the person’s agent, advises the health entity that the person wishes to undergo a consulting assessment, and
(c) the entity does not provide, to persons to whom health care is provided at the health establishment, access to the request and assessment process at the establishment.
(2) The health entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person’s first assessment may be carried out by a relevant practitioner for the person.
(3) In making a decision under subsection (2) about the reasonable steps that may be taken to facilitate the transfer of the person, the health entity must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
(4) In this section—
relevant practitioner, for a person, means—
(a) the person’s consulting practitioner, or
(b) a medical practitioner to whom the person’s consulting practitioner has referred a matter under section 37.
104
Written declarations
104 Written declarations
104 Written declarations
(1) This section applies if—
(a) the person has been assessed as eligible for access to voluntary assisted dying, and
(b) the person or the person’s agent advises the health entity that the person wishes to make a written declaration, and
(c) the entity does not provide, to persons to whom health care is provided at the residential premises, access to the request and assessment process at the facility.
(2) The health entity must take reasonable steps to facilitate the transfer of the person to and from a place where the person may make a written declaration.
(3) In making a decision under subsection (2) about the reasonable steps that may be taken to facilitate the transfer of the person, the health entity must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
105
Application for administration decision
105 Application for administration decision
105 Application for administration decision
(1) This section applies if—
(a) the person has made a final request, and
(b) the person or the person’s agent advises the health entity that the person wishes to make an application for an administration decision, and
(c) the entity does not provide, to persons to whom relevant services are provided at the health establishment, access to a person’s coordinating practitioner to enable the application to be made.
(2) The health entity must take reasonable steps to facilitate the transfer of the person to and from the place where the person’s coordinating practitioner can consult with and assess the person in relation to the application.
(3) In making a decision under subsection (2) about the reasonable steps that may be taken to facilitate the transfer of the person, the health entity must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
pt.5-div.3-sdiv.3
Administration of voluntary assisted dying substance
pt.5-div.3-sdiv.3 Administration of voluntary assisted dying substance
Subdivision 3 Administration of voluntary assisted dying substance
106
Administration of voluntary assisted dying substance
106 Administration of voluntary assisted dying substance
106 Administration of voluntary assisted dying substance
(1) This section applies if—
(a) the person has made an administration decision, and
(b) the person or the person’s agent advises the health entity that the person wishes to self-administer a voluntary assisted dying substance or have the person’s administering practitioner administer a voluntary assisted dying substance to the person, and
(c) the health entity does not provide, to persons to whom health care is provided at the health establishment, access to the administration of a voluntary assisted dying substance at the establishment.
(2) The health entity must take reasonable steps to facilitate the transfer of the person to a place where the person may be administered, or may self-administer, a voluntary assisted dying substance.
(3) In making a decision under subsection (2) about the reasonable steps that may be taken to facilitate the transfer of the person, the health entity must have regard to the following—
(a) whether the transfer would be likely to cause serious harm to the person,
(b) whether the transfer would be likely to adversely affect the person’s access to voluntary assisted dying,
(c) whether the transfer would cause undue delay and prolonged suffering in accessing voluntary assisted dying,
(d) whether the place to which the person is proposed to be transferred is available to receive the person,
(e) whether the person would incur financial loss or costs because of the transfer.
pt.5-div.3-sdiv.4
Information about non-availability of voluntary assisted dying
pt.5-div.3-sdiv.4 Information about non-availability of voluntary assisted dying
Subdivision 4 Information about non-availability of voluntary assisted dying
107
Relevant entities to inform public about non-availability of voluntary assisted dying
107 Relevant entities to inform public about non-availability of voluntary assisted dying
107 Relevant entities to inform public about non-availability of voluntary assisted dying
(1) This section applies to a health entity that does not provide, at a health establishment at which the entity provides health care, services associated with voluntary assisted dying, including access to the request and assessment process or access to the administration of a voluntary assisted dying substance.
(2) The health entity must publish information about the fact the entity does not provide any services, or services of a specified type, associated with voluntary assisted dying at the health establishment.
(3) The health entity must publish the information in a way in which it is likely that persons who receive health care at the health establishment will become aware of the information.
Part 6
Review by Supreme Court
Part 6 Review by Supreme Court
Part 6 Review by Supreme Court
108
Definitions
108 Definitions
108 Definitions
In this Part—
eligible applicant means—
(a) a patient who is the subject of a decision referred to in section 109(1)(a)–(d), or
(b) a person who has been appointed by a patient mentioned in paragraph (a) as the patient’s agent—
(i) in writing, or
(ii) by other means the Supreme Court considers satisfactory in the circumstances, or
(c) another person who has a sufficient and genuine interest in the rights and interests of a patient referred to in paragraph (a) in relation to voluntary assisted dying.
party to the proceeding, in relation to a review application, means a party to the proceeding before the Supreme Court relating to the application.
review application, in relation to a patient, means an application under section 109(1) for a review of a decision made in relation to the patient.
reviewed decision, in relation to a review application, means the decision the subject of the application.
109
Application for review of certain decisions by Supreme Court
109 Application for review of certain decisions by Supreme Court
109 Application for review of certain decisions by Supreme Court
(1) An eligible applicant may apply to the Supreme Court for a review of any of the following decisions—
(a) a decision of a patient’s coordinating practitioner in a first assessment that the patient—
(i) at the time of making the first request, has or has not been ordinarily resident in New South Wales for a period of at least 12 months, or
(ii) has or does not have decision-making capacity in relation to voluntary assisted dying, or
(iii) is or is not acting voluntarily, or
(iv) is or is not acting because of pressure or duress,
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(b) a decision of a patient’s consulting practitioner in a consulting assessment that the patient—
(i) at the time of making the first request, has or has not been ordinarily resident in New South Wales for a period of at least 12 months, or
(ii) has or does not have decision-making capacity in relation to voluntary assisted dying, or
(iii) is or is not acting voluntarily, or
(iv) is or is not acting because of pressure or duress,
(c) a decision of a patient’s coordinating practitioner to make a statement in a final review form certifying that the coordinating practitioner is satisfied the patient—
(i) has or does not have decision-making capacity in relation to voluntary assisted dying, or
(ii) in requesting access to voluntary assisted dying—
(A) is or is not acting voluntarily, or
(B) is or is not acting because of pressure or duress, and
(d) a decision of the Board to refuse an application for a voluntary assisted dying substance authority in relation to a patient.
(2) A review of a reviewed decision—
(a) is to be dealt with as a new hearing, and
(b) evidence or information may be given in addition to, or in substitution for, the information given in relation to the reviewed decision.
110
Patient party to proceedings
110 Patient party to proceedings
110 Patient party to proceedings
If a review application is made in relation to a patient, the patient is a party to the proceeding whether or not the patient is the applicant for the review.
111
Consequences of review application
111 Consequences of review application
111 Consequences of review application
(1) This section applies if a review application is made in relation to a patient.
(2) If the request and assessment process in relation to the patient has not been completed—
(a) the request and assessment process is suspended, and
(b) no further step in the process is to be taken until the review application is decided or otherwise disposed of.
(3) If the request and assessment process in relation to the patient has been completed—
(a) the process for accessing voluntary assisted dying under Part 4 is suspended, and
(b) no step under that Part, including the prescription, supply or administration of a voluntary assisted dying substance, is to be taken in relation to the patient until the review application is decided or otherwise disposed of.
112
Review application taken to be withdrawn if patient dies
112 Review application taken to be withdrawn if patient dies
112 Review application taken to be withdrawn if patient dies
A review application made in relation to a patient is taken to be withdrawn if the patient dies.
113
Decision of Supreme Court
113 Decision of Supreme Court
113 Decision of Supreme Court
In deciding a review application made in relation to a patient, the Supreme Court may decide that—
(a) at the time of making the first request, the patient had been ordinarily resident in New South Wales for a period of at least 12 months, or
(b) at the time of making the first request, the patient had not been ordinarily resident in New South Wales for a period of at least 12 months, or
(c) the patient has decision-making capacity in relation to voluntary assisted dying, or
(d) the patient does not have decision-making capacity in relation to voluntary assisted dying, or
(e) the patient is acting voluntarily, or
(f) the patient is not acting because of pressure or duress, or
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(g) the patient is not acting voluntarily, or
(h) the patient is acting because of pressure or duress, or
(i) a ground to refuse to issue a voluntary assisted dying substance authority exists, or
(j) a ground to refuse to issue a voluntary assisted dying substance authority does not exist.
More sections below
Source text: opening excerpt
Sourced from legislation.nsw.gov.au, CC BY 4.0.
Part 1 Preliminary
Part 1 Preliminary
Part 1 Preliminary
Division 1 Preliminary
Division 1 Preliminary
Division 1 Preliminary
1 Name of Act
1 Name of Act
1 Name of Act
This Act is the Voluntary Assisted Dying Act 2022.
2 Commencement
2 Commencement
2 Commencement
This Act commences on the day that is 18 months after the date of assent to this Act.
3 Act to bind Crown
3 Act to bind Crown
3 Act to bind Crown
This Act binds the Crown in right of New South Wales and, in so far as the legislative power of the Parliament of New South Wales permits, the Crown in all its other capacities.
Division 2 Principles
Division 2 Principles
Division 2 Principles
4 Principles
4 Principles
4 Principles
(1) A person exercising a power or performing a function under this Act must have regard to the following principles—
(a) every human life has equal value,
(b) a person’s autonomy, including autonomy in relation to end of life choices, should be respected,
(c) a person has the right to be supported in making informed decisions about the person’s medical treatment and should be given, in a way the person understands, information about medical treatment options, including comfort and palliative care and treatment,
(d) a person approaching the end of life should be provided with high quality care and treatment, including palliative care and treatment, to minimise the person’s suffering and maximise the person’s quality of life,
(e) a therapeutic relationship between a person and the person’s health practitioner should, wherever possible, be supported and maintained,
(f) a person should be encouraged to openly discuss death and dying, and the person’s preferences and values regarding the person’s care, treatment and end of life should be encouraged and promoted,
Creates a private-review mechanism: eligible applicants may apply to the Supreme Court for a de novo review of certain practitioner or Board decisions (Part 6, ss 109-116). A review application suspends the request and assessment process and any Part 4 steps while it is pending (s 111).
Regulates supply, storage and disposal tightly (ss 73-83), including authorisation of suppliers and disposers by Gazette notice (s 84), labelling (s 77) and a steel locked-box requirement (s 79).
Imposes offences and penalties for false or misleading information (s 123), unauthorised disclosure or recording (s 126), improper publication of Part 6 material (s 127), failures to give forms (many form provisions with maximum penalties, typically 100 penalty units) and specified criminal penalties for cancelled prescriptions and improper handling of substances (ss 124, 125).
Confers protections from civil and criminal liability for good faith compliance with the Act (ss 130-133), and states that, for State law purposes, a death resulting from a prescribed administration in accordance with the Act is not a suicide (s 12).
The Act gives the Board and the Health Secretary defined roles in operational oversight and information collection (ss 136, 174). The Minister retains a supervisory and administrative direction power over the Board (s 141) and may require statistical reporting of particular matters (s 170(2)). The Act also sets out institutional participation choices and minimum access obligations: institutions may decline to participate (s 89) but must not hinder access to information and must facilitate practitioner attendance or patient transfer in specified circumstances (ss 90-107).
Official rationale material is embedded in the statutory structure: the Principles in s 4 set out values to be "had regard to" by persons exercising powers under the Act (including the Supreme Court, s 4(2)). Those principles include equal value of life, respect for autonomy and palliative care access, regional equality of access, protection from pressure or duress and respect for cultural and religious beliefs (s 4(1)(a)-(k)). The Act implements those policy aims through eligibility controls, multiple independent medical safeguards, administrative oversight by the Board, data collection (s 170) and an access standard to address regional access (s 174). The mechanics of that implementation create administrative duties, statutory records and time limits; they also create formal points of discretion (for the Board, Health Secretary, Minister and practitioners) and statutory penalties for breaches.
Key implementation levers are the Health Secretary's ability to approve substances and issue guidelines and standards (ss 7, 174, 180-182), and the Board's gatekeeper role in authorising the supply authority (ss 70-72). The Supreme Court review mechanism (Part 6) operates as a legal safety valve for disputes about residency, capacity, voluntariness and pressure or duress (s 109), and the Act suspends processes while a review is pending (s 111).
Main concepts
This Act defines and organises a set of interlocking legal and clinical concepts. Each concept carries procedural consequences specified in the text.
Eligibility: Section 16 sets out the statutory eligibility criteria. The patient must be an adult, satisfy nationality or residency thresholds (s 16(1)(b)-(c)), carry at least one qualifying disease that is advanced, progressive and will cause death within a specified prognosis (s 16(1)(d)(i)-(ii)), be experiencing suffering not tolerable to them (s 16(1)(d)(iii)), have decision-making capacity for voluntary assisted dying (s 16(1)(e)), act voluntarily and not because of pressure or duress (s 16(1)(f)-(g)), and have an enduring request (s 16(1)(h)). The Act expressly excludes eligibility based solely on disability, dementia or certain mental health impairments (s 16(2)).
Decision-making capacity: Section 6 defines capacity for the Act’s purposes in functional terms: understanding, remembering, appreciating the matters, weighing factors and communicating the decision (s 6(1)). There is a presumption of capacity unless shown otherwise (s 6(2)). Loss of capacity during the process ends eligibility (s 16(3)).
Pressure or duress: The Act requires that decisions must not be made because of pressure or duress (s 16(1)(g)). The Dictionary (Schedule 1) contains the defined term (referred to in s 4 and elsewhere). Practitioners must ask about pressure from beneficiaries (e.g., s 30(4)(n), 41(4)(n)) and follow Health Secretary guidelines for assessing pressure or duress (s 181(2)(c)).
Coordinating, consulting and administering practitioners: The Act creates distinct practitioner roles with eligibility requirements (coordinating/consulting in s 18; administering in s 55) and separate duties at each step (e.g., coordinating practitioner conducts first assessment s 25; consulting practitioner must independently assess s 36; administering practitioner implements practitioner administration s 60).
Request and assessment process: A statutory procedural ladder: first request (s 19), first assessment (ss 25-30), consulting assessment (ss 31-41), written declaration (ss 43-47), final request and final review (ss 48-52), and then administration decision and supply (Pt 4 Div 2).
Voluntary assisted dying substance and authority: Health Secretary approves substances (s 7) and the Board grants a voluntary assisted dying substance authority after considering required documents (ss 70-72). Only authorised suppliers may prepare and supply substances (s 59(4), 60(4)).
Forms, records and notification regime: Numerous "approved forms" are mandated and must be given to the Board within stated timeframes: first request form (s 23), first assessment report (s 30), consultation referral (s 34), consulting assessment report (s 41), written declaration (s 47), final request form (s 51), final review form (s 52), administration decision form (s 57), prescription form (s 61), practitioner administration form (s 62), authorised supply and disposal forms (ss 78, 81), and practitioner transfer forms (ss 64, 175). Failure to give specified forms attracts maximum penalties, often 100 penalty units (see e.g., ss 30(2), 34(1), 41(2), 47, 51(1), 52(4), 57(6), 61(1), 78(3), 81(3), 83(3), 171).
Institutional participation and access obligations: Entities (residential facilities and health entities) may refuse to provide voluntary assisted dying services (s 89(1)-(2)), but if they do not provide services they must not hinder access to information and must allow or facilitate practitioner attendance or patient transfer in many circumstances (ss 90-106). Entities that decline must publish non-availability notices (ss 98, 107).
Oversight, data and reporting: The Board is tasked with monitoring the Act, maintaining lists of willing practitioners (s 136(1)(a)-(b)), collecting and keeping specified statistical information (s 170), preparing an annual report (s 173) and potentially referring matters to other agencies (s 136(1)(f)). The Health Secretary must issue an access standard addressing how access will be facilitated, with particular attention to regional residents (s 174).
Legal review: Part 6 empowers eligible applicants to seek a new hearing in the Supreme Court to review certain practitioner decisions and Board refusals (s 109). A review suspends ongoing processes (s 111); the Court may substitute its decision and that substitution can have specified legal effects (ss 113-115).
Each concept is connected to specific duties, forms, timeframes and compliance obligations that shape the incentives of practitioners, institutions and the Board. For example, the multiple independent assessments, written declaration with witness rules (ss 43-45) and Board authorisation (ss 70-72) create sequential gates intended to test capacity, voluntariness and compliance with the Act’s standards.
Who it affects
The Act names and prescribes roles for specific actors. It also creates consequential obligations for related bodies.
Patients and their agents: Any adult seeking voluntary assisted dying is directly affected by the eligibility criteria (s 16) and the procedural requirements (Pt 3 and Pt 4). Patients must make a first request, may withdraw at any time (s 20), must make a written declaration witnessed according to specific rules (ss 43-45) and make an administration decision (ss 57-58). A patient who chooses self-administration must appoint a contact person (ss 57(3)(a), 66-68).
Medical practitioners: Practitioners operate as coordinating, consulting or administering practitioners and must meet eligibility requirements (s 18 for coordinating/consulting; s 55 for administering). Practitioners decide to accept or refuse requests or referrals (ss 21, 32) but must record decisions and notify the Board within prescribed timeframes (e.g., ss 22, 23, 34). Practitioners are subject to professional-conduct consequences: the Act notes contraventions may constitute unsatisfactory professional conduct or misconduct under the Health Practitioner Regulation National Law (s 11; s 10 Note; s 131(3)).
Contact persons and agents: For self-administration the contact person has a statutory role and must consent, comply with guidelines (s 67(1)(e)(i)-(ii)), may refuse to continue (s 69) and bears duties to handle unused substances and to inform the coordinating practitioner of death (ss 68(2), 125). Agents may collect and deliver substances on a patient’s behalf in limited authorised ways (s 59(7)).
Authorised suppliers and authorised disposers: The Health Secretary may authorise classes of registered health practitioners to supply or dispose of prescribed substances (s 84). Such persons are required to authenticate prescriptions (s 75), give required written information at supply (s 76), attach statements to packaging (s 77) and submit supply and disposal forms to the Board within 5 business days (ss 78(3), 81(3)). Failure to comply attracts penalties (various provisions impose 100 penalty units).
Health care establishments and residential facilities and their owners: These entities may choose not to provide voluntary assisted dying services (s 89(1)-(2)). Where they decline, they retain obligations not to hinder access to information and, in many circumstances, must permit practitioner attendance, or facilitate transfer to a place where assessments or administration may occur (ss 90-107). Entities that decline must publish their non-availability status (ss 98, 107).
The Voluntary Assisted Dying Board: Created by s 134 and given monitoring, gatekeeping and reporting functions (s 136). The Board keeps lists of willing practitioners (s 136(1)(b)) and grants substance authorities (ss 71-72). The Board holds records and must keep a register of authorised suppliers and disposers (s 84(6)).
The Health Secretary and Minister: The Health Secretary approves substances (s 7), issues the access standard (s 174), issues guidelines and approves training and resources (ss 180-181, 182). The Minister may give written directions to the Board (s 141) and can require the Board to disclose specified information (s 142). The Minister is also responsible for periodic statutory reviews of the Act’s operation (s 186).
Courts and regulators: The Supreme Court is given a central review role (Part 6) for disputes about residency, capacity, voluntariness and pressure or duress (s 109). Other bodies will be engaged through referrals by the Board (s 136(1)(f)), and the Act cross-references the Health Practitioner Regulation National Law with respect to professional conduct (s 11).
Who pays and costs are not directly itemised in the Act text. The Act creates administrative reporting burdens and forms which impose time and record-keeping obligations on practitioners, authorised suppliers and the Board (numerous sections requiring forms to be lodged within 5 business days, e.g., ss 23, 30, 34, 41, 47, 51, 52, 57, 61, 78, 81, 83). Those are compliance costs borne by practitioners, entities operating facilities, suppliers/disposers and the Board. The Health Secretary must provide staff and facilities to support the Board (s 139), indicating a public administrative cost. The Act also contemplates facilitation of transfers and practitioner attendance at facilities; those practical steps are operational burdens falling on entities that do not provide services but must facilitate access in certain circumstances (ss 92-106).
Finally, the Act affects information flows: practitioners, the Board and the Health Secretary will hold and use sensitive personal and medical information, with strict prohibitions on unauthorised recording, disclosure or publication (s 126, s 127). The Board is required to collect and report specified statistical information (s 170) and to prepare an annual report (s 173).
Key duties and rights
The Act sets out the legal duties of practitioners, entities and the Board, and the statutory rights of patients and other persons. Below are the principal duties and rights expressed in the text, with section references.
Duties on medical practitioners
Decide to accept or refuse first requests and referrals and notify patients within specified timeframes (s 21(1)-(4); s 32(1)-(4)). The reasons for refusal are limited by the Act (s 21(2); s 32(2)).
Record the first request and decision in the medical record (s 22).
If accepting a first request, act as the coordinating practitioner (s 24).
Conduct a first assessment and decide on each eligibility criterion (s 25(1)-(2)); refer to other medical practitioners or psychiatrists where unable to decide (ss 26-27).
Provide specified information to patients assessed as meeting the eligibility criteria, including diagnosis, prognosis, treatment and palliative options, risks, and the requirement for a written declaration and witnesses (s 28(1)). The practitioner must take reasonable steps to fully explain clinical guidelines and a plan for administration (s 28(4)).
Complete and submit required forms to the Board within prescribed timeframes (numerous sections, e.g., s 23, s 30(2), s 34(1), s 41(2), s 47).
Prescribe a voluntary assisted dying substance only subject to a Board authority (s 59(3), s 60(3)) and comply with the detailed prescription and supply rules (s 74-76).
For administering practitioners, certify in an approved practitioner administration form after administration with specific details (s 62), and supply the Board with the form within 5 business days (s 62(4)).
Duties and powers of the Board and Health Secretary
Board: monitor operation, keep lists of willing practitioners, decide residency exemption applications (s 17(1)-(2); s 136(1)(b), (c)), grant/refuse voluntary assisted dying substance authorities, maintain registers of authorised suppliers/disposers (ss 71-72; s 84(6)), collect and use information, and report annually (ss 136, 170, 173). The Board must notify receipt of forms (s 171) and notify the Health Secretary of disposal forms (s 171(2)).
Health Secretary: approve voluntary assisted dying substances (s 7), issue access standard (s 174), approve forms and training and guidance (ss 180-182, 182), issue guidelines on referrals and assessment of pressure or duress (s 181), and publish the access standard (s 174(5)).
Rights and protections for practitioners and others
Conscientious objection: registered health practitioners have the right to refuse participation if they have a conscientious objection (s 9(1)); subsection (2) and (3) make clear the exemption is not limited.
Liability protection: persons acting in good faith and with reasonable care in accordance with the Act or believing on reasonable grounds they are acting in accordance with the Act do not incur civil or criminal liability and their actions are not to be treated as breaches of professional ethics or grounds for professional misconduct (s 131).
Specific protection for medical practitioners referring patients or requesting records under the Act (s 132): such acts are permitted despite other laws and do not attract sanction by professional regulators solely because of making the referral or request.
Protection for persons assisting or present (s 130): those present at an administration in accordance with the Act or assisting in good faith do not incur criminal liability.
Protection for emergency responders and health practitioners not to administer lifesaving treatment when they reasonably believe the person is dying after lawful self- or practitioner-administration (s 133).
Patient rights and safeguards
Right to decide not to proceed at any time (s 20(1); s 54).
Right to be informed about treatment options, palliative care, outcomes and risks (s 4(1)(c), s 28(1)).
Right to withdraw an administration decision at any time; revocation must be recorded and notified (s 58).
Right that a death in accordance with this Act not be considered suicide for State law purposes (s 12(1)).
Right to an independent judicial review in the Supreme Court for certain practitioner or Board decisions (s 109); the review is a new hearing (s 109(2)) and suspends the process while pending (s 111).
Institutional duties and limits
Residential facilities and health entities may refuse to provide services relating to voluntary assisted dying (s 89(1)-(2)), but if they do not provide such services they must facilitate access to information and allow reasonable practitioner attendance or patient transfer when requested (ss 90-107). If an entity declines to provide services it must publish the non-availability information (ss 98, 107).
Record-keeping and notification duties
Many mandatory forms must be completed and sent to the Board or Health Secretary within 5 business days at various steps (e.g., ss 23, 30(2), 34(1), 41(2), 47, 51(1), 52(4), 57(6), 61(1), 78(3), 81(3), 83(3)). The Board must notify receipt (s 171).
Offences and penalties create duties
False or misleading statements in connection with any purpose or requirement under the Act are an offence under the Crimes Act, Part 5A (s 123) and hence subject to criminal sanctions.
Unauthorised recording, use or disclosure of information obtained under the Act is an offence with a maximum penalty of imprisonment for 12 months (s 126(1)), save for express statutory exceptions (s 126(2)).
Improper publication of personal information concerning a Part 6 proceeding is an offence with a maximum 12 months imprisonment (s 127).
These duties and rights structure the behaviour of clinicians, institutions, the Board and the Health Secretary: clinicians are gatekeepers and record-keepers with specific timing duties; institutions may refuse participation but must facilitate access; the Board and Health Secretary set standards and collect data; patients retain the right to change their mind at any time. Compliance is enforced both by professional-regulatory consequences (cross-referencing the National Law) and by statutory penalties and criminal offence provisions in Part 7.
Penalties and enforcement
The Act establishes a mixed enforcement regime combining administrative oversight, statutory offences and professional accountability pathways. Enforcement mechanisms and sanctions are spread across the Act and linked to specific procedural requirements.
Administrative enforcement and reporting
The Board is the central administrative monitor and gatekeeper. It receives and records required forms, maintains registers of authorised suppliers and disposers (s 84(6)), and must notify receipt of forms (s 171). The Board also has powers to refer matters to other agencies including police, the Registrar of Births, Deaths and Marriages, the State Coroner and professional regulators (s 136(1)(f)). The Board grants or refuses voluntary assisted dying substance authorities (ss 71-72) and must refuse a substance authority if required documents are missing or it suspects non-compliance (s 72(1)). When refusing, the Board must notify the coordinating practitioner within 2 business days with reasons (s 72(2)).
The Health Secretary oversees standards (s 174), guidelines (s 181), forms (s 182) and authorisation of substances (s 7). The Health Secretary may audit and instruct the Board (ss 141-142).
Criminal offences and imprisonment
False or misleading information: The Act makes it an offence under the Crimes Act 1900, Part 5A for a person to make statements known to be false or misleading or omit information that renders a statement misleading for any purpose under this Act (s 123). The Act references the Crimes Act category but does not state a separate maximum penalty within this text.
Specific criminal penalties with imprisonment:
Cancellation reporting: An authorised supplier who cancels a document presented as a prescription must notify the Health Secretary and may face imprisonment for 12 months where the supplier is satisfied the document does not comply or is false (s 124(2), maximum penalty imprisonment 12 months).
Contact person obligations: Failure by a contact person to deliver unused substance to an authorised disposer within 14 days after revocation or death attracts a maximum penalty of imprisonment for 12 months (s 125(1)-(2)). The contact person has explicit statutory duties and possible imprisonment for non-compliance.
Unauthorised recording, use or disclosure of information obtained because of a function under the Act: maximum penalty imprisonment for 12 months (s 126(1)). Statutory exceptions include use for Act functions or court proceedings (s 126(2)).
Publication of personal information about a Part 6 proceeding: maximum penalty imprisonment for 12 months (s 127(1)).
Monetary penalties and administrative fines
Many obligations to complete and give forms to the Board carry a maximum penalty of 100 penalty units where specified (for example: s 30(2) first assessment report, s 34(1) consultation referral form, s 41(2) consulting assessment report form, s 47 written declaration to Board, s 51(1) final request form, s 52(4) final review form, s 57(6) administration decision form, s 61(1) prescription form, s 78(3) authorised supply form, s 81(3) authorised disposal form, s 83(3) practitioner disposal form). The Act does not set the monetary value of a penalty unit here but consistent statutory practice in NSW means it is a non-negligible financial sanction. These penalties are typically framed as "maximum penalty,100 penalty units", signalling civil or regulatory enforcement.
Professional discipline and regulatory overlap
The Act expressly states that contraventions by registered health practitioners may constitute unsatisfactory professional conduct or professional misconduct under the Health Practitioner Regulation National Law (s 11). The Act also states that withdrawal of usual services by a treating practitioner because of a patient’s request is unlawful and may be unsatisfactory professional conduct (s 28(1)(k)(ii)-(3)). Sections 10 and 28 contain notes that a contravention may be professional misconduct under the National Law, indicating professional regulators are an enforcement channel.
Section 132 provides protections to medical practitioners who refer or request records under the Act, insulating them from punishment under other laws and from professional sanction for making referrals or requests.
Poisons Act enforcement linkage
The Act makes Part 5, Divisions 2-4 of the Poisons and Therapeutic Goods Act 1966 (referred to as the “applied provisions”) apply for enforcement of this Act, with necessary modifications (s 128). Section 14 asserts that when inconsistency exists between this Act and the Poisons and Therapeutic Goods Act 1966 or the Drug Misuse and Trafficking Act 1985, this Act prevails to the extent of the inconsistency. Practically, enforcement mechanisms and offences relating to poison handling and supply are therefore brought into the enforcement architecture for the voluntary assisted dying substances, with regulatory adaptations.
Judicial review and suspension
Part 6 allows eligible applicants to apply to the Supreme Court for a review of certain practitioner decisions and Board refusals (s 109). Where a review application is made, the Act suspends the request and assessment process (s 111(2)) or if the process had been completed, suspends Part 4 steps including prescription, supply and administration (s 111(3)). These suspension effects are self-executing statutory enforcement mechanisms that pause further actions until the Court decides or disposes of the application. The Supreme Court may substitute its decision for the reviewed decision (s 114) or may find that the patient is ineligible (s 115). The Court’s hearings are to be held in private (s 117), with protections on publication of personal information (s 121).
Referral and cross-agency enforcement
The Board may refer matters it identifies to police, coroners, registrars and professional regulators (s 136(1)(f)). The Act requires the registrar of a convicting court to notify the Health Secretary and the Board of convictions under the Act (s 129).
Other enforcement features
The Act also contains specific prohibitions (e.g., no structured administration and supply arrangements, s 86), and a framework for authorising suppliers and disposers by Gazette notice (s 84) with registration and public inspection restrictions (s 84(6)-(7)). The register is only inspectable by a limited class of persons (s 84(7)).
In sum, enforcement mixes criminal penalties for certain misuses and unauthorised disclosures, substantial monetary penalties for record and notification breaches, professional regulatory exposure for practitioners, administrative monitoring and Board gatekeeping, and judicial review with suspension of processes. The Act also imports enforcement tools from the Poisons and Therapeutic Goods Act for handling and disposal offences.
How it interacts with other laws
The Act is interleaved with a number of existing statutory regimes. The text itself contains explicit primacy clauses, cross-references and carve-outs that determine legal interaction.
Primacy and inconsistencies
The Act contains an express inconsistency rule: if there is an inconsistency between a provision of this Act and a provision of the Poisons and Therapeutic Goods Act 1966 or the Drug Misuse and Trafficking Act 1985, this Act prevails to the extent of the inconsistency (s 14). This creates a limited legal primacy for voluntary assisted dying supply, possession and disposal rules over those Acts where they conflict.
Application of Poisons Act enforcement provisions
The Poisons and Therapeutic Goods Act 1966 Part 5 Divisions 2-4 are made applicable for enforcement of this Act, with prescribed and other necessary modifications (s 128(1)). The Act also states a definition in that Poisons Act of a term used in the applied provisions applies for the purposes of s 128(2). This imports much of the Poisons Act’s enforcement machinery into the regulatory architecture for voluntary assisted dying substances, albeit with modifications and where consistent with this Act.
Health Practitioner Regulation National Law and professional regulation
Multiple sections acknowledge overlap with professional disciplinary regimes. Contraventions of the Act by registered health practitioners may constitute unsatisfactory professional conduct or professional misconduct under the Health Practitioner Regulation National Law (s 11). The Act protects practitioners who refer or request information under the Act from punishment under other laws or censure by professional regulators for making the referral or request (s 132). Section 131(3) states that acts done in good faith and with reasonable care under the Act are not to be regarded as a contravention of professional ethics or a ground for unsatisfactory professional conduct.
Crimes Act and criminal law
The Act references the Crimes Act for false and misleading statements (s 123) and specifically references s 41C of the Crimes Act in relation to the offence of applying pressure or duress (see s 28(1)(j) Note, and elsewhere). The Act excludes voluntary assisted dying action from constituting suicide for State law purposes (s 12(1)) and clarifies that voluntary assisted dying action does not provide a basis for police action under the Mental Health Act provision that otherwise treats attempts to cause serious physical harm (s 12(2)). These cross-references shape how criminal law and mental health law apply in the VAD context.
Coroners, births and deaths registration and police
The Act requires medical practitioners giving cause-of-death certificates to identify when they know or reasonably believe the person accessed voluntary assisted dying under the Act and to record the qualifying disease (s 87(4)-(6)). The Board may refer matters relevant to voluntary assisted dying to the Commissioner of Police, the Registrar of Births, Deaths and Marriages, the State Coroner, and other bodies (s 136(1)(f)).
Guardianship and powers of attorney
The Act expressly provides that voluntary assisted dying is not a matter to which the Guardianship Act 1987 or the Powers of Attorney Act 2003 apply, nor may provision be made under instruments under those Acts for voluntary assisted dying (s 184). This removes adult substitute decision-making instruments under those Acts from operating to authorise voluntary assisted dying.
Other statutory reporting and administrative obligations
The Act requires the Health Secretary to include palliative care spending and activity data in the Ministry’s annual report framework (s 185), thereby integrating the VAD regime’s oversight into public health reporting.
Privacy and information law
The Act contains strict prohibitions on recording, use or disclosure of information obtained by reason of a function under this Act (s 126) with statutory exceptions (s 126(2)). The Board may disclose non-personal information to public authorities or persons for education or research (s 169), and the Board must keep and publish statistical information as required by s 170, but the Act limits the Board’s annual report from including personal information (s 173(3)(a)).
Administrative law and the Minister’s powers
The Minister may give directions to the Board about performance of its functions (s 141) but cannot direct the Board about performance in relation to a particular person or matter (s 141(3)). The Minister can also compel disclosure of information from the Board (s 142) subject to personal-information limits (s 142(2)).
Interpreters and accreditation
The Act cross-references interpreter accreditation and limits interpreter eligibility (s 183). The Health Secretary, by Gazette notice, may approve accredited bodies (s 183(1)(a)).
Courts and judicial secrecy
The Supreme Court’s review proceedings are to be held in private (s 117). Publication of personal information connected with Part 6 proceedings is forbidden (s 127), and the Court must ensure published decisions exclude personal information (s 121).
In practical terms, the Act both imports existing regulatory frameworks (Poisons Act for handling of substances, Health Practitioner Regulation National Law for professional regulation) and creates carve-outs (s 14 primacy, s 184 Guardianship and Powers of Attorney exclusions). It also creates pathways for inter-agency cooperation via the Board’s referral powers (s 136(1)(f)). The Act’s cross-references shape the legal landscape for practitioners, the Board, hospitals and registrars, and limit the application of substitute decision-making laws to voluntaries assisted dying.
Amendment history
The Act text contains limited internal amendment signals and a commencement clause, and notes at least one schedule entry showing amendment and repeal history of a schedule item.
Commencement: The Act does not commence immediately but comes into operation on the day that is 18 months after assent (s 2). That delayed commencement creates a defined implementation window for regulators to prepare standards, guidance, training and administrative structures (Health Secretary and Board duties in Pt 10 and Pt 11).
Schedule and repeal note: The included Schedule 1A is marked as "Repealed" and includes an amendment note: "sch 1A: Am 2023 No 7, Sch 2.50. Rep 1987 No 15, sec 30C." This shows that at least part of the instrument’s schedules has already been the subject of amendment and repeal action recorded in the text. No other specific amendment chronology or dates are supplied within the provided text.
Ongoing review requirement: The Act mandates statutory reviews of its operation. The Minister must review the operation and effectiveness of the Act and prepare a report as soon as practicable after the second anniversary of the day on which s 186 comes into operation and thereafter at intervals not exceeding five years (s 186(1)). The review must consider the principles in s 4, with particular attention to access for regional residents (s 186(2)). The report must be laid before each House of Parliament within a specified period (s 186(3)). These statutory reviews create recurring opportunities for formal amendment recommendations to Parliament.
Regulations and delegated instruments: Section 187 empowers the Governor to make regulations prescribing matters required or permitted under the Act or necessary or convenient for its operation. The Act also delegates various administrative details to the Health Secretary by Gazette notice,approvals of substances (s 7), authorising suppliers/disposers (s 84), designation of authorised officials for public information (s 178(4)), approval of an official voluntary assisted dying care navigator service (s 179(1)) and the Health Secretary’s power to approve forms (s 182). These powers identify the primary vehicles for non-legislative change and operational amendment via statutory instruments and Gazette notices.
Board delegations and internal governance: The Board may delegate many functions to members or committees (s 138) and the Minister can give written directions to the Board (s 141). These mechanisms allow internal operational changes without primary-legislation amendment.
The Act itself does not list a wider amendment history beyond the Schedule note. The statutory review mandating reports (s 186) will serve as the formal parliamentary mechanism to propose legislative changes at two years and thereafter every five years, which is the embedded legislative amendment pathway.
Litigation history
The Act sets up a specific statutory route for judicial scrutiny rather than providing a catalogue of prior litigation. The text does not name any cases or record prior judicial decisions under the Act. Instead, it prescribes the litigation mechanism and protections that will govern future disputes.
Statutory review route: Part 6 (ss 108-122) creates a de novo review procedure before the Supreme Court for eligible applicants to challenge certain practitioner decisions and Board refusals. Section 109(1) lists the decisions that may be reviewed: practitioner decisions under first or consulting assessments concerning ordinary residence (12-month requirement), decision-making capacity for voluntary assisted dying, whether the patient is acting voluntarily, and whether the patient is acting because of pressure or duress; decisions in final review forms by a coordinating practitioner on capacity or voluntariness; and decisions of the Board to refuse a voluntary assisted dying substance authority (s 109(1)(a)-(d)). Section 109(2) confirms that a review is to be dealt with as a new hearing where additional evidence is permitted.
Procedural consequences on review: Section 111 suspends the request and assessment process or Part 4 access steps while a review application is on foot. Section 112 automatically withdraws a review application if the patient dies. The Supreme Court’s powers to decide are enumerated in s 113, and s 114-115 set out the legal consequences of the Court’s determinations, including when the Court substitutes its decision for the reviewed decision and when the outcome is to render the patient ineligible.
Private and confidential hearings: Hearings are to be in private (s 117). The Principal Registrar must give notice of an application to coordinating/consulting practitioners, administering practitioners where relevant, the Health Secretary and the Board (s 118). The Court must give written reasons and provide those to parties and relevant officials (s 120), and protect personal information when publishing reasons or decisions (s 121). There are criminal prohibitions against publishing personal information about Part 6 proceedings (s 127).
Procedural participation duties: Practitioners must supply statements of reasons and relevant documents to the Court when a review application is made (s 119), within seven business days or a shorter period ordered by the Court (s 119(2)).
No cases named: The Act text does not cite or name any judicial decisions or precedent; therefore the Act itself contains no litigation history. The statutory litigation pathway (Part 6) is the instrument’s explicit method for resolving the enumerated disputes; actual litigation history will be created after commencement and through cases brought under s 109.
Because the Act provides a full and public procedure for judicial review of certain decisions, the Supreme Court is anticipated to be the primary forum where contested determinations (residency, capacity, voluntariness, pressure or duress, Board refusals) will be litigated. The Act mandates private hearings and restrictions on publication of personal information in those proceedings (ss 117, 121, 127), and gives the Court power to make interim orders on a review application (s 122).
In short: the Act contains no pre-existing litigation record. Instead it establishes a defined judicial pathway, procedural rules and confidentiality protections that will govern future litigation under the statute.
Gotchas
The Act contains a number of technical, procedural and practical pitfalls that practitioners, institutions and patients should note. These are not interpretations but direct implications drawn from the statutory wording. Each item cites the controlling provision.
Strict form and timing obligations with penalties. Many steps require submission of approved forms to the Board within 5 business days and carry specified maximum penalties (commonly 100 penalty units). Examples include the first assessment report form (s 30(2)), consulting assessment report form (s 41(2)), written declaration (s 47), final request form (s 51(1)), final review form (s 52(4)), administration decision form (s 57(6)), prescription form (s 61(1)), authorised supply and disposal forms (ss 78(3), 81(3)), and practitioner disposal form (s 83(3)). Failure to comply attracts statutory maximum penalties. Practitioners must build administrative capacity to meet these timelines.
Witness eligibility rules for written declarations and witnessing administrations. The written declaration requires two witnesses and specifies ineligible witnesses (s 44). Section 45 requires witnesses to certify the voluntariness of the patient and that they are not ineligible witnesses. For practitioner administration witness eligibility excludes family members or employees of the administering practitioner (s 63(2)). These rules are detailed and can invalidate or complicate downstream steps if not followed cautiously.
Contact person mandatory for self-administration and duties thereof. A patient who chooses self-administration must appoint a contact person (s 15(g), s 57(3)(a), s 66). The contact person has legal responsibilities: they are authorised to receive and handle the substance (s 68(1)), must inform the coordinating practitioner if the patient dies (s 68(2)), and if unused substances remain after revocation or death they must give them to an authorised disposer within 14 days or face imprisonment up to 12 months (s 125(1)-(2)). Failing to secure an eligible and willing contact person can delay or prevent self-administration.
Storage requirement: locked steel box. Any person who receives a voluntary assisted dying substance must store it in a locked box made of steel and not easily penetrable and locked with a sturdy lock (s 79). This is a specific physical-security standard, and the authorised supplier must inform the recipient about storage requirements (s 76(2)(b)). Non-compliance risks statutory offences via related poison handling enforcement provisions (s 128).
Institutions may refuse services but must facilitate access in certain situations. Residential facilities and health entities may decline to provide VAD services (s 89(1)-(2)), but if they do they must not hinder access to information and must allow reasonable access to a practitioner or facilitate transfers depending on whether the person is a permanent resident and the circumstances (ss 90-107). The practical effect is a tension between institutional non-participation rights and statutory duties to facilitate access,coordination and clear policies within facilities are necessary to manage requests and transfers lawfully.
Prohibition on initiating discussion by health care workers except in narrowly defined circumstances. Health care workers who provide services must not initiate a discussion about voluntary assisted dying or suggest it, subject to limited exceptions for medical practitioners who must also inform patients about standard treatments and palliative options (s 10(1)-(3)). This is a conduct restriction that interacts with informed consent and clinical communication norms; failing to comply may expose practitioners to professional conduct proceedings (s 10 Note, s 11).
Board gatekeeping and potential for refusal. The Board may refuse to issue a voluntary assisted dying substance authority if required documents are missing or if it suspects statutory requirements have not been met (s 72(1)), and it must give written notice with reasons within 2 business days (s 72(2)). Coordinating practitioners must plan for this gatekeeper step before prescribing (s 59(3), s 60(3), s 71).
Judicial suspension of the process on review. If an eligible applicant applies to the Supreme Court under s 109, s 111 suspends the request and assessment process or access steps under Part 4 while the review is pending. Practitioners must be alert to potential review applications and the automatic suspension effect, which may disrupt time-sensitive clinical plans.
Confidentiality and publication prohibitions. The Act creates strict prohibitions on recording, using or disclosing information obtained under the Act (s 126), with limited statutory exceptions. Part 6 proceedings are private (s 117), and publication of personal information concerning such proceedings is a criminal offence (s 127). Practitioners, media and institutions must take care in handling information and communications.
Interaction with guardianship and enduring instruments: excluded. The Act expressly removes voluntary assisted dying from the scope of the Guardianship Act 1987 and Powers of Attorney Act 2003 (s 184). This can be a trap for practitioners relying on enduring instruments or attorneys to assent to VAD decisions: such instruments do not authorise VAD under this Act.
Prescription and supply constraints. The prescription must clearly indicate it is for a voluntary assisted dying substance, certify completion of the process, state the administration decision type, include the patient’s telephone number and not be in the form of a medication chart or provide for repeat supply (s 74). The coordinating practitioner must give the prescription directly to an authorised supplier (s 74(5)). Authorised suppliers must authenticate the prescription and identity (s 75) and submit authorised supply forms (s 78). These are tight administrative controls which, if breached, can create cancelled prescriptions and criminal exposure for suppliers (s 124).
Prohibition on structured administration and supply arrangements. The Act forbids issuing a document that sets out circumstances in which a class of health professionals may administer or supply a medicine for VAD (s 86). Employers or institutions used to standing orders or NP supply pathways need to be aware this is disallowed.
Palliative-care reporting obligation. The Health Secretary must include detailed palliative-care expenditure and service provision data in the Ministry’s annual report (s 185). Agencies and hospitals may therefore be required to supply data for public reporting.
Definitions and prognosis thresholds. Section 16(d)(ii) differentiates prognosis timelines: 12 months for neurodegenerative disease or 6 months otherwise. Practitioners must assess prognosis on the balance of probabilities and may need specialist input (s 26, s 37). These prognostic thresholds are statutory gates and liable to disagreement.
Eligibility exclusions for certain conditions. A person is not eligible merely because of a disability, dementia or certain mental health impairments (s 16(2)), and the Act expressly warns that dementia alone does not suffi ce to meet eligibility (s 16(1)(d) Note). Assessors must therefore ensure the qualifying disease and prognosis are explicitly satisfied.
Each of these technical requirements is a compliance hinge where administrative error, delayed notification, unsuitable witnesses, missing authorisations, or miscommunication can create legal exposure, process suspension, or denial of access. Practitioners and institutions should map workflows to the statutory steps and time limits and to the Board/Health Secretary's guidance and forms.
How to comply
This section sets out a practical, source-grounded checklist-style pathway to comply with the Act’s principal steps and associated statutory requirements. Citations are provided to the controlling provisions. This is procedural guidance based on the Act’s text; it does not substitute for legal or clinical advice.
Understand eligibility up front (s 16)
Confirm the person is an adult and meets citizenship or residency conditions (s 16(1)(a)-(c)). If the 12-month ordinary-residence requirement might not be met, consider applying for a residency exemption under s 17 with the Board and gather evidence of a substantial connection or compassionate grounds (s 17(1)-(2)).
Verify the patient has a qualifying disease, illness or medical condition: advanced, progressive and expected to cause death within the statutory timeframes (s 16(1)(d)(i)-(ii)) and that the suffering is not tolerable to the patient (s 16(1)(d)(iii)).
Assess decision-making capacity for VAD per the Act’s functional test (s 6). Keep in mind the presumption of capacity unless proven otherwise (s 6(2)). If decision-making capacity is in doubt, plan referrals under s 27/38.
Ensure voluntariness and absence of pressure or duress (s 16(1)(f)-(g)); follow Health Secretary guidelines on pressure/duress (s 181(2)(c)).
First request and coordinating practitioner role (ss 19-25)
The patient must make a first request during a medical consultation, clear and unambiguous, in person if practicable (s 19(1)-(3)). If in-person is not practicable, audiovisual is allowed under s 176(1).
The recipient medical practitioner must decide to accept or refuse within statute limits and notify the patient within 2 business days unless conscientious objection requires immediate refusal notice (s 21(1)-(4)).
Record the first request and decision in the medical record (s 22).
Complete the first request form and provide a copy to the Board within 5 business days (s 23(1)-(2)). Coordinate administrative workflows to meet the 5-business-day deadline.
First assessment by coordinating practitioner (ss 25-30)
If the practitioner accepts, they become the coordinating practitioner (s 24). The coordinating practitioner must assess eligibility and decide on each criterion (s 25(1)-(2)).
If uncertain about diagnosis/prognosis, refer to appropriate specialist under s 26 and adopt the specialist’s report where suitable (s 26(2)-(4)). If unsure about capacity, voluntariness or pressure/duress, refer to a psychiatrist or other appropriate person per s 27.
If assessed as meeting eligibility criteria, inform the patient in writing and explain diagnosis, treatment, palliative options, potential risks of VAD substances, and other information mandated by s 28(1). Take reasonable steps to fully explain clinical guidelines and an administration plan (s 28(4)).
Complete the first assessment report form and give it to the Board within 5 business days; give a copy to the patient as soon as practicable (s 30(2)-(3)). Note the maximum penalty attached (s 30(2)).
Consulting assessment and independent check (ss 31-41)
Refer the patient to a consulting practitioner for an independent assessment if the first assessment found eligibility (s 31).
The consulting practitioner must independently assess all eligibility criteria and make an independent decision (s 36(1)-(2)). If unsure, make referrals under ss 37-38.
The consulting practitioner must inform patient and coordinating practitioner of the outcome and complete the consulting assessment report form and provide it to the Board within 5 business days (s 41(1)-(3)).
Written declaration (ss 43-47)
A patient assessed as eligible by both coordinating and consulting practitioners may make an approved-form written declaration (s 43(1)-(2)).
Ensure the declaration states voluntariness, absence of pressure or duress, and understanding of effect (s 43(3)(a)). If the patient cannot sign, follow substituted-signature rules (s 43(4)-(5)) and ensure certification by the interpreter where relevant (s 43(6)).
Use two eligible witnesses (s 44). Avoid ineligible witnesses (s 44(2)) and obtain the required witness certifications (s 45).
Record the declaration in the medical record (s 46) and give a copy to the Board within 5 business days (s 47), noting the maximum penalty.
Final request and final review (ss 48-52)
The patient may make a final request in person (or audiovisual if not practicable) after the consulting assessment is complete and not before the end of the designated period unless early final request criteria are met (ss 48-49).
The coordinating practitioner must record the final request date and reasons if made early (s 50) and complete the final request form for the Board within 5 business days (s 51).
On receipt of final request, the coordinating practitioner must perform the final review: review all consulting assessment forms and the
(g) a person should be supported in conversations with the person’s health practitioners, family, carers and community about care and treatment preferences,
(h) a person is entitled to genuine choices about the person’s care, treatment and end of life, irrespective of where the person lives in New South Wales and having regard to the person’s culture and language,
(i) a person who is a regional resident is entitled to the same level of access to voluntary assisted dying and high quality care and treatment, including palliative care and treatment, as a person who lives in a metropolitan region,
(j) there is a need to protect persons who may be subject to pressure or duress,
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(k) all persons, including health practitioners, have the right to be shown respect for their culture, religion, beliefs, values and personal characteristics.
(2) In subsection (1), the reference to a person exercising a function under this Act includes the Supreme Court exercising its jurisdiction in relation to a decision made under this Act.
Division 3 Interpretation
Division 3 Interpretation
Division 3 Interpretation
5 Definitions
5 Definitions
5 Definitions
The Dictionary in Schedule 1 defines words and expressions used in this Act.
Note—
The Interpretation Act 1987 also contains definitions and other provisions that affect the interpretation and application of this Act.
6 Decision-making capacity
6 Decision-making capacity
6 Decision-making capacity
(1) For the purposes of this Act, a patient has decision-making capacity in relation to voluntary assisted dying if the patient has the capacity to—
(a) understand information or advice about a voluntary assisted dying decision required under this Act to be provided to the patient, and
(b) remember the information or advice referred to in paragraph (a) to the extent necessary to make a voluntary assisted dying decision, and
(c) understand the matters involved in a voluntary assisted dying decision, and
(d) understand the effect of a voluntary assisted dying decision, and
(e) weigh up the factors referred to in paragraphs (a), (c) and (d) for the purposes of making a voluntary assisted dying decision, and
(f) communicate a voluntary assisted dying decision in some way.
(2) For the purposes of this Act, a patient is—
(a) presumed to have the capacity to understand information or advice about voluntary assisted dying if it reasonably appears the patient is able to understand an explanation of the consequences of making the decision, and
(b) presumed to have decision-making capacity in relation to voluntary assisted dying unless the patient is shown not to have the capacity.
(3) In this section—
voluntary assisted dying decision means—
(a) a request for access to voluntary assisted dying, or
(b) a decision to access voluntary assisted dying.
7 Voluntary assisted dying substance
7 Voluntary assisted dying substance
7 Voluntary assisted dying substance
(1) The Health Secretary may, in writing, approve a Schedule 4 poison or Schedule 8 poison for use under this Act for the purpose of causing a patient’s death.
(2) A poison approved under subsection (1) is a voluntary assisted dying substance.
(3) The Health Secretary must keep a list of voluntary assisted dying substances.
8 When request and assessment process completed
8 When request and assessment process completed
8 When request and assessment process completed
For the purposes of this Act, the request and assessment process has been completed in relation to a patient if the patient’s coordinating practitioner—
(a) has completed the final review form in relation to the patient, and
(b) has certified in the final review form that the request and assessment process has been completed in accordance with this Act.
Division 4 Other provisions
Division 4 Other provisions
Division 4 Other provisions
9 Registered health practitioner may refuse to participate in voluntary assisted dying
9 Registered health practitioner may refuse to participate in voluntary assisted dying
9 Registered health practitioner may refuse to participate in voluntary assisted dying
(1) A registered health practitioner who has a conscientious objection to voluntary assisted dying has the right to refuse to do any of the following—
(a) participate in the request and assessment process,
(b) prescribe, supply or administer a voluntary assisted dying substance,
(c) be present at the time of the administration of a voluntary assisted dying substance.
(2) Subsection (1) does not limit the circumstances in which a registered health practitioner may refuse to do any of the things referred to in the subsection.
10 Health care worker not to initiate discussion about voluntary assisted dying
10 Health care worker not to initiate discussion about voluntary assisted dying
10 Health care worker not to initiate discussion about voluntary assisted dying
(1) A health care worker who provides health services or professional care services to a person must not, while providing the services to the person—
(a) initiate a discussion with the person that is in substance about voluntary assisted dying, or
(b) in substance, suggest voluntary assisted dying to the person.
Note—
A contravention of this Act is capable of constituting unsatisfactory professional conduct or professional misconduct for the purposes of the Health Practitioner Regulation National Law, whether or not the contravention constitutes an offence.
(2) Subsection (1) does not apply to a medical practitioner who initiates a discussion or makes a suggestion referred to in subsection (1)(a) or (b) if, at the time the discussion is initiated or the suggestion is made, the medical practitioner also informs the person about the following—
(a) the treatment options available to the person that would be considered standard care for the disease, illness or medical condition with which the person has been diagnosed,
(b) the likely outcomes of the treatment options available to the person,
(c) the palliative care and treatment options available to the person,
(d) the likely outcomes of the palliative care and treatment options.
(3) Also, subsection (1) does not apply to a health care worker, other than a medical practitioner, who initiates a discussion or makes a suggestion referred to in subsection (1)(a) or (b) if, at the time the discussion is initiated or the suggestion is made, the health care worker also informs the person that the person—
(a) has palliative care and treatment options available, and
(b) should discuss the palliative care and treatment options with the person’s medical practitioner.
(4) To avoid doubt, subsection (1) does not apply to a health care worker who provides information about voluntary assisted dying to a person at the person’s request.
(5) In this section—
health care worker means—
(a) a registered health practitioner, or
(b) another person who provides health services or professional care services.
11 Contravention of Act by registered health practitioner
11 Contravention of Act by registered health practitioner
11 Contravention of Act by registered health practitioner
(1) A contravention of a provision of this Act by a registered health practitioner is capable of constituting unsatisfactory professional conduct or professional misconduct for the purposes of the Health Practitioner Regulation National Law.
(2) Subsection (1) applies whether or not the contravention constitutes an offence under this Act.
12 Voluntary assisted dying not suicide
12 Voluntary assisted dying not suicide
12 Voluntary assisted dying not suicide
(1) For the purposes of the law of the State, a person who dies as the result of the administration of a prescribed substance in accordance with this Act does not die by suicide.
(2) Voluntary assisted dying action does not—
(a) constitute an attempt by the person to cause serious physical harm to the person for the purposes of the Mental Health Act 2007, section 22, or
(b) otherwise provide a ground for a police officer to take action under that section.
(3) In this section—
voluntary assisted dying action means any of the following done in accordance with this Act—
(a) a request for access to voluntary assisted dying,
(b) a self-administration decision or a practitioner administration decision,
(c) self-administration by a person of a prescribed substance,
(d) asking an administering practitioner to administer a prescribed substance.
13 Inherent jurisdiction of Supreme Court not affected
13 Inherent jurisdiction of Supreme Court not affected
13 Inherent jurisdiction of Supreme Court not affected
Nothing in this Act affects the inherent jurisdiction of the Supreme Court.
14 Relationship with Poisons and Therapeutic Goods Act 1966 and Drug Misuse and Trafficking Act 1985
14 Relationship with Poisons and Therapeutic Goods Act 1966 and Drug Misuse and Trafficking Act 1985
14 Relationship with Poisons and Therapeutic Goods Act 1966 and Drug Misuse and Trafficking Act 1985
If there is an inconsistency between a provision of this Act and a provision of the Poisons and Therapeutic Goods Act 1966 or the Drug Misuse and Trafficking Act 1985, the provision of this Act prevails to the extent of the conflict or inconsistency.
Part 2 Requirements for access to voluntary assisted dying
Part 2 Requirements for access to voluntary assisted dying
Part 2 Requirements for access to voluntary assisted dying
15 When person may access voluntary assisted dying
15 When person may access voluntary assisted dying
15 When person may access voluntary assisted dying
A person may access voluntary assisted dying if—
(a) the person has made a first request, and
(b) the person has been assessed as eligible for access to voluntary assisted dying by—
(i) the person’s coordinating practitioner, and
(ii) the person’s consulting practitioner, and
(c) the person has made a written declaration, and
(d) the person has made a final request to the person’s coordinating practitioner, and
(e) the person’s coordinating practitioner has certified in a final review form that—
(i) the request and assessment process has been completed in accordance with this Act, and
(ii) the practitioner is satisfied of each of the matters referred to in section 52(3)(f), and
(f) the person has made an administration decision, and
(g) if the person has made a self-administration decision—the person has appointed a contact person, and
(h) a voluntary assisted dying substance authority has been issued by the Board in relation to the person.
16 Eligibility criteria
16 Eligibility criteria
16 Eligibility criteria
(1) The following criteria must be met for a person to be eligible for access to voluntary assisted dying—
(a) the person is an adult,
(b) the person—
(i) is an Australian citizen, or
(ii) is a permanent resident of Australia, or
(iii) at the time of making a first request, has been resident in Australia for at least 3 continuous years,
(c) at the time of making a first request, the person has been ordinarily resident in New South Wales for a period of at least 12 months,
(d) the person is diagnosed with at least 1 disease, illness or medical condition that—
(i) is advanced, progressive and will cause death, and
(ii) will, on the balance of probabilities, cause death—
(A) for a disease, illness or medical condition that is neurodegenerative—within a period of 12 months, or
Note—
See subsection (2)(b) which provides that a person is not eligible for access to voluntary assisted dying merely because the person has dementia.
(B) otherwise—within a period of 6 months, and
(iii) is causing suffering to the person that cannot be relieved in a way the person considers tolerable,
(e) the person has decision-making capacity in relation to voluntary assisted dying,
(f) the person is acting voluntarily,
(g) the person is not acting because of pressure or duress,
Note—
See the definition of pressure or duress in the Dictionary in Schedule 1.
(h) the person’s request for access to voluntary assisted dying is enduring.
(2) A person is not eligible for access to voluntary assisted dying merely because the person has—
(a) a disability, or
(b) dementia, or
(c) a mental health impairment within the meaning of the Mental Health and Cognitive Impairment Forensic Provisions Act 2020.
(3) To avoid doubt, if a person permanently loses decision-making capacity in relation to voluntary assisted dying at any time during the request and assessment process the person ceases to be eligible for a
This is an opening excerpt, not the complete document.